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Abstract
Single-walled carbon nanotube based materials possess unique physical properties
which can be used in the biomedical and therapeutical applications. For example,
biocompatible nanotubes can serve as an optical imaging tool, for use in vitro and
in vivo. Several groups, including us, demonstrated that individualized nanotubes,
at low concentration (quantification of this criterion has been done in this work),
have no apparent cytotoxicity to cells. However, their long-term influence on cellular
structures and activities have to be investigated.
Our focus is on the interaction between a specific cell type, neural stem cells,
and nanotubes. It is reported here that the internalized nanotubes at therapeutical
concentrations can still vary the cell behavior substantially, which is of significant
interest for both a fundamental biophysics and an applied bioengineering. In par-
ticular, in this work carbon nanotubes have been shown to serve as a mediator for
neuronal differentiation. This effect has not been previously experimentally observed
or theoretically investigated.
Traditionally, research on the implantation of neural stem cells to integrate into
existing circuitry and replace damaged cell populations has focused on trying to con-
trol cellular differentiation through the use of external cues. Such perturbations
cause the cells to alter their structure to adapt to their surrounding and could pro-
mote a certain line of differentiation. In this study, we took a different approach by
using the nanotubes as internal cues to affect the cell response.
The internalization of biofunctionalized single-wall carbon nanotubes at properly
chosen concentrations (1-10 pM) by neural stem cells (C17.2) has been studied. The
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results of our study suggest that the tubes mediate the neuronal differentiation of
C17.2 cells. They are also shown here to give rise to development of a cell type
not typically observed in the C17.2 cell line. Changing the wrapping of the carbon
nanotubes from a specific non-biological ssDNA ((GT )20) to a natural tRNA did not
deter the mediating effect, allowing to identify the carbon nanotubes as being solely
responsible for stimulating neuronal differentiation.
In trying to understand the mechanisms behind the change of cell behavior ob-
served during this stimulated differentiation, we focused on the dynamics of the
asymmetric cell division. The latter gives rise to the diversity in the final population
of cells. A complex dynamics has been observed, dependent on details of nanotube
intervention. Disruption of the cytoskeleton fibers, such as actin and nestin, when
carbon nanotubes were added has been also observed in neural stem cells. These
results are worth considering when developing physical models for neural stem cell
engineering and, ultimately the strategies to neurodegeneration recovery therapies.
2
Chapter 1
Introduction to Nanomaterials
1.1 Nanomaterials
The term nanotechnology gained popularity in the 1980s and 1990s, but technologies
that use nanomaterials have been around for centuries. The Lycurgus Cup is a 4th-
century Roman glass cage cup made of a dichroic glass, which shows a different color
depending on whether or not light is passing through it; red when lit from behind
and green when lit from in front. It is the only complete Roman glass object made
from this type of glass, and the one exhibiting the most impressive change in color;
Analytical transmission electron microscopy revealed the presence of minute particles
of metal, typically 50-100 nm in diameter. Nanoparticles of silver-gold alloy, with
a ratio of silver to gold of about 7:3, containing an addition of about 10 % copper
were mixed together producing the dichroic effect [1, 2]. Another application of
nanomaterials was in stained glass windows used in churches in medieval Europe.
Glass artisans mixed gold chloride into molten glass, unknowingly reducing the gold
complexes to form small gold nanoparticles [3, 4]. By virtue of their small size, the
trapped particles exhibited a surface plasmon resonance effect to imbue the glass
with a ruby red color [5] After several decades, the ingredients present in the stained
glass of various churches were classified subsequent to the development of analytical
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instruments. The relationship between the color of stained glass and the size/shape
of the nanoparticles are summarized in Fig. 1.1 [4].
Figure 1.1: Comparison of the effect of size and shape of nanoparticles on the coloring
of stained glass (Stained Glass Museum, Great Britain)[4]
One of the influences behind nanotechnology started with the talk by physicist
Richard Feynman at the California Institute of Technology (CalTech) entitled ”There
is Plenty of Room at the Bottom”. In his talk, Feynman described a process in which
scientists would be able to manipulate and control individual atoms and molecules
[6]. Over a decade later, in his explorations of ultraprecision machining, Professor
Norio Taniguchi coined the term nanotechnology. It was with the development of
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the scanning tunneling microscope that the study of nanomaterials started gaining
ground [7] .
Today, nanotechnology covers a wide range of disciplines including the frontiers
of physics, chemistry, biology, medicine, materials and more [8, 9, 10]. This emerging
field focuses on the study and application of structures having at least one physical
dimension at the nanoscale level (i.e. between 1-100 nm). These nanomaterials
exhibit unique properties depending on their atomic structure, size confinement,
composition, defects and interfaces, all of which can be tailored by synthesis and
other processes [3]. This has opened numerous avenues to emerging technological
applications.
Titanium dioxide is a white solid used in house paint and certain candy-coated
chocolates. Titanium dioxide nanoparticles are so small that they do not reflect
visible light, so they cannot be seen. They are used in sunblock creams because they
block harmful ultraviolet light from the Sun without appearing white on the skin
[11].
A synthetic skin, that may be used in prosthetics, has been demonstrated with
both self healing capability and the ability to sense pressure. The material is a
composite of nickel nanoparticles and a polymer. If the material is held together
after a cut it seals itself in about 30 minutes giving it a self healing ability. Also the
electrical resistance of the material changes with pressure, giving it a sense ability
like touch. [8].
1.2 Nanoparticles in Health and Medicine
Nanomaterials, having sizes comparable to proteins and biomolecules inside the cell
have shown a new viewpoint to tackle medical illnesses and improve diagnostics and
regeneration. Interactions of these materials with biomolecules can be studied both
in the extracellular medium and inside the cells as shown in fig. 1.2. Operating at
nanoscale allows exploitation of physical properties that are different from those used
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at the macro- or micro- scale level and may allow direct targeting and interaction
with the surface of the biological samples.
Magnetic nanoparticles (MNPs) have been successfully used to isolate and group
stem cells [12, 13, 14]. Quantum dots are now being used for molecular imaging and
tracking of stem cells,while nanomaterials such as carbon nanotubes, and fluorescent
nanoparticles are used for delivery of genes or drugs into stem cells [15, 16, 17]
Unique nanostructures are being designed to control and regulate proliferation and
differentiation of cells. All these advances speed up the development of stem cell
research toward the application of stem cells in regenerative medicine [18].
Nanotechnology can also be a valuable tool to track and image cells [18], to drive
stem cells differentiation into specific cell lineage [19, 20] and ultimately to under-
stand their biology [21, 22]. The research of stem cell-based therapeutics focuses on
the prevention, diagnosis and treatment of human diseases [23, 24].
Figure 1.2: Use of nanoparticles in stem cell research [23]
Other than in regenerative research, nanomaterials help in the development of
novel tools and platforms for understanding biological systems and disease diagnosis
and treatment. For instance, implants, such as orthopedic ones and heart valves, are
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made of titanium and stainless steel alloys [25, 26]. These alloys are primarily used
in humans because they are biocompatible, i.e., they do not adversely react with
human tissue. In the case of orthopedic implants (artificial bones for hip, etc.), these
materials are non-porous. For an implant to effectively mimic a natural human bone,
the surrounding tissue must penetrate the implants, thereby affording the implant
with the required strength [25, 26].
Since these materials are relatively impervious, human tissue does not pene-
trate the implants, thereby reducing their effectiveness. Furthermore, these metal
alloys wear out quickly necessitating frequent, and often very expensive, surgeries.
Nanocrystalline zirconia (zirconium oxide) ceramic is hard, wear-resistant, corrosion-
resistant (biological fluids are corrosive), and biocompatible material. Nanoceram-
ics can also be made porous by converting it into aerogels through sol-gel tech-
niques. Nanocrystalline zirconia provides for far less frequent implant replacements
are needed, and hence, a significant reduction in surgical expenses. Nanocrystalline
silicon carbide (SiC) is a candidate material for artificial heart valves primarily due
to its low weight, high strength, extreme hardness, wear resistance, inertness (SiC
does not react with biological fluids), and corrosion resistance [25, 26].
Another interesting use of nanoparticles is in the treatment of neurodegenera-
tive disorders [27]. For the delivery of central nervous system (CNS) therapeutics,
various nano carriers such as, dendrimers, nano gels, nano emulsions, liposomes,
polymeric nano particles, solid lipid nano particles, and nano suspensions have been
studied. Transportation of these nano medicines has been effected across various in
vitro and in vivo blood brain barrier (BBB) models by endocytosis with early pre-
clinical success for the management of CNS conditions such as Alzheimer’s disease,
brain tumors, HIV encephalopathy and acute ischemic stroke has become possible
[28, 29, 30]. The nanomedicine can be advanced further by improving their BBB
permeability and reducing their neurotoxicity as shown in Fig. 1.3. Trans-activator
of transcription (Tat) peptide-modified gold nanoparticles were used as a platform to
deliver an anticancer drug, doxorubicin, and imaging agents, such as Gd3+ contrast
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agents, to brain tumor tissues in mice [19]. Increased survival rate in mice treated
with nanoparticle-complexed doxorubicin was observed when compared with those
treated with free doxorubicin. Further, the peptide-nanoparticle complex was also
effective in delivering the Gd3+ contrast agent as observed by enhanced brain tumor
imaging and prolonged retention time of Gd3+ chelates.
Figure 1.3: Ways by which nanoparticles can cross BBB [31]
Recent reports shed light on adverse effects of nanotoxicity at organ, tissue,
cellular and protein levels [32]. Factors governing the toxicity of nanoparticles
include their size, shape, surface modification, chemical composition and physico-
electrochemical properties. Nanoparticles have been particularly implicated in car-
diovascular and pulmonary toxicities as a result of inhalation of these ultra-fine
substances [33]. Bhabra et al. have shown that cobaltchromium nanoparticles can
induce DNA damage in cells without crossing the plasma membrane barrier mediated
through gap junctions [34]. Metal-based nanoparticles have been shown to interact
with a number of different proteins and enzymes and lead to generation of reactive
oxygen species through interference with the antioxidant defense mechanism. This
in turn leads to the induction of inflammatory response, thus resulting in apoptosis
or necrosis [32].
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Chapter 2
Introduction to Carbon Nanotubes
2.1 Single Walled Carbon Nanotubes
CNTs exhibit unparalleled physical, mechanical, and chemical properties which have
attracted tremendous interest in the past decade [35, 36, 37]. Theoretical and ex-
perimental results have shown extremely high elastic modulus, greater than 1 TPa
and reported strengths 10-100 times higher than the strongest steel at a fraction of
the weight. They are also thermally stable up to 2800◦C in vacuum, have thermal
conductivity about twice as high as diamond, and electric current carrying capacity
1000 times higher than copper wires [35, 38, 39, 40]. In this thesis, we focus on
the use of carbon nanotubes (CNTs) for biomedical purposes. Therefore, properties
of CNTs such as their stability, capabilities for functionalization and their optical
properties will be discussed.
Depending on the number of graphene layers from which a single nanotube is com-
posed, CNTs are classified as single-walled carbon nanotubes (SWCNTs) or multi-
walled carbon nanotubes (MWCNTs) [36, 37]. Study of CNTs span many fields
and applications [41, 42], including composite materials [43], nanoelectronics [44],
field-effect emitters [45], and hydrogen storage[46]. Researchers at Stanford Univer-
sity have demonstrated a method to make integrated circuits and a small computer
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using all CNT based transistors. In order to make the circuit work they developed
methods to remove metallic nanotubes, leaving only semiconducting nanotubes, as
well as an algorithm to deal with misaligned nanotubes [47].
CNTs can be visualized as a sheet of graphene which has been rolled into a tube
[36, 37]. Unlike diamond, where a 3-D crystal structure is formed with each carbon
atom having four nearest neighbors arranged in a tetrahedron, graphene, a single
layer of graphite, is formed as a 2-D sheet of carbon atoms arranged in a hexagonal
array. As shown in Fig. 2.1, each carbon atom has three nearest neighbors in the
sp2 configuration. [48]. The properties of nanotubes depend on atomic arrangement,
diameter and length of the tubes, and morphology or structure [35, 36, 37].
Figure 2.1: Atomic structure of diamond compared to graphite [48]
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In Fig. 2.2, the two unit vectors a1 and a2 describe the unit cell. In the case of
SWCNT, the graphene lattice vector Ch=na1+ma2 becomes the circumference of the
tube. The circumference vector, Ch, is called the chiral vector. It is determined by
the pair of integers (n,m) where n and m are the integers of the vector θ consisting of
the unit vectors a1 and a2. We can visualize cutting the graphite sheet and rolling
the tube so that the tip of the chiral vector touches its tail. The resulting rolled
nanotubes can possess planes of symmetry both parallel and perpendicular to the
nanotube axis (such as the non-chiral zigzag and armchair nanotube in Fig. 2.2),
while others do not (such as the chiral nanotube in Fig. 2.2). The chiral nanotubes
are unable to be superimposed on their own image in a mirror. [36, 37]
Figure 2.2: Definition of the roll-up vector as linear combinations of base vectors a1 and
a2. Zigzag: θ= 0 (n, 0); chiral: 0 < θ < 30 (n,m); armchair: θ = 30 (n,n)
[49]
11
The diameter of the tube is given by the length of the chiral vector:
d =
| Ch |
pi
=
a0
pi
√
n2 + nm+m2 (2.1)
where a0=2.461A˚ is the equilibrium length of carbon-carbon chemical bond. Be-
cause of its one-dimensionality (1D), SWCNT imparts strong quantum confinement
and weak dielectric screening. Therefore, the Coulomb interaction strength is large
compared with the conventional 3D solids. Optical transitions in nanotubes are dom-
inated by correlated electron-hole bound states known as excitons [36, 37, 50]. Their
properties define various optical phenomena observed in SWCNT: optical absorption
[51, 52], photoluminescence (PL) [53, 54], and Raman scattering [55, 56, 57]. Under-
standing of SWCNT electronic structure and optical properties helps in gauging its
potential for use [58, 59, 60].
2.2 Functionalization of Carbon Nanotubes
Several techniques are used to grow nanotubes: laser ablation, catalytic chemical
vapor deposition (CVD), arc-discharge, high-pressure carbon monoxide dispropor-
tionation (HiPco) CVD. All of these produce SWCNTs which are inherently difficult
to handle as they tend to aggregate in bundles through strong attractive interactions
[37, 50, 61]. The absorption spectra of these bundles show very broad bands in visi-
ble and NIR range. The PL of CNTs in bundles is difficult to observe due to rapid
nonradiative decay of excitons in semiconducting nanotubes into metallic ones or
semiconducting with the smaller band gap. Therefore, the development of function-
alization methods to obtain stable suspensions of individualized carbon nanotubes is
primordial [36, 37]. Functionalization of CNTs has been performed by covalent and
noncovalent approaches shown in Fig. 2.3 [62, 63, 64, 61].
Covalent functionalization is based on covalent linkage of functional entities onto
the nanotube scaffold. It can be performed at the termini of the tubes or at their
sidewalls. The direct covalent sidewall approach changes the extent of hybridization
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from sp2 up to sp3. Defect functionalization takes advantage of chemical trans-
formations of defect sites already present. Defect sites can be the open ends and
holes in the sidewalls, terminated, for example, by carboxylic groups [61, 62, 63, 64].
Thus, covalent modification (i.e. amidation [65], esterification [61], reduction of nitro
groups [66] and cleavable disulfides [67]) changes the structural, optical and electrical
properties of CNTs.
On the other hand, non-covalent approaches retain CNTs in their most native
state through use of adsorption forces, such as van der Waals, hydrophobic forces
and pi-stacking interactions. The non-covalent functionalization is also an alternative
method for tuning the interfacial properties of nanotubes. The CNTs are function-
alized non-covalently by aromatic compounds, surfactants, and polymers, employing
pi-pi stacking or hydrophobic interactions for the most part. In these approaches, the
non-covalent modifications of CNTs can do much to preserve their desired properties,
while improving their solubilities quite remarkably.
Aromatic small molecule absorption, polymer wrapping, surfactants, biopolymers
and endohedral method are some types of non covalent modification which have been
used to funtionalize CNTs [62, 63, 64, 68]. Endohedral functionalization of CNTs is
the filling of the tubes with atoms or small molecules [69]. Non-covalent methods are
usually quite simple and quick, involving steps such as ultrasonication, centrifugation
and filtration.
Further development of sample purity and structural selectivity were obtained by
density gradient ultracentrifugation (DGU) method. It allows sorting of CNT sus-
pension by aggregate or individualized CNT size, diameter, chirality and metallicity
[57, 70, 71, 68]. Today, one of the remaining problems in the dispersion procedure
is potential damage during sonication process [72] and relatively low yields for the
high purity (electronic grade) material [73].
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Figure 2.3: Functionalization possibilities for SWCNTs: A) defect-group functionaliza-
tion, B) covalent sidewall functionalization, C) non-covalent exohedral func-
tionalization with surfactants, D) non-covalent exohedral functionalization
with polymers, and E) endohedral functionalization with, for example, C60.
For methods B-E, the tubes are drawn in idealized fashion, but defects are
found in real situations [62]
2.3 DNA Wrapped Carbon Nanotubes
Deoxyribonucleic acid (DNA) is one of the fundamental biological molecules and has
been thoroughly studied since the discovery of its structure in 1953 by Watson and
Crick (31) [74]. DNA is a biological polymer comprised of four types of monomer
nucleotides [75]. A nucleotide itself is composed of a negatively charged hydrophilic
region (the phosphate group), a sugar ring which are both known as the backbone,
and a hydrophobic region (one of four nitrogenous aromatic base). The bases are
adenine, guanine, thymine, and cytosine, (abbreviated A, G, T, and C, respectively)
[76]. Thymine and cytosine contain the benzene derivative pyrimidine, which has
nitrogen substituted for carbon at positions one and three of the six-member ring.
Adenine and guanine are known as purines, possessing a pyrimidine ring fused with
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a five-member imidazole ring [74, 75, 77]. Each unit is approximately 0.34 nm long.
Single strands of DNA (ssDNA) can be synthetically fabricated with a high yield
and purity in lengths up to 100 nucleotides.
Figure 2.4: A) The four bases of DNA showing their complementary binding properties
B) DNA nucleotide.
The DNA double helix has two polynucleotide chains that run in opposite direc-
tions and are twisted around each other right-handedly. Each strand of the double
helix is a linear chain consisting of a phosphate-sugar backbone held together by
hydrogen bonds between complimentary bases [76]. In particular, ”A” is comple-
mentary to ”T” and ”G” to ”C”. The A-T pair has two hydrogen bonds while G-C
has three. At least three DNA conformations are believed to be found in nature,
A-DNA, B-DNA, and Z-DNA. The ”B” form described by James D. Watson and
Francis Crick is believed to predominate in cells [78]. It is 23.7 A˚ wide and extends
34 A˚ per 10 base pair of sequence. The double helix makes one complete turn about
its axis every 10.4 base pairs in a solution. This frequency of twist, known as the
helical pitch depends largely on stacking forces that each base exerts on its neighbors
in the chain [79].
A-DNA and Z-DNA differ significantly in their geometry and dimensions to B-
DNA, although still forming a helical structures [80, 81, 82]. The A form appears
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likely to occur only in dehydrated samples of DNA, such as those used in crystal-
lographic experiments, and possibly in hybrid pairings of DNA and RNA strands
[80]. The Z geometry has strands which turn about the helical axis the opposite
way to A-DNA and B-DNA [82]. There is evidence of protein-DNA complexes form-
ing Z-DNA structures. Other conformations are also possible. Under stretching or
twisting, B-DNA can transform into overstretched S-DNA [83] or overwound P-DNA
[84].
Figure 2.5: Different Congigurations of DNA [78]
In early stidies, atomic force microscope (AFM) images of DNA/CNT hybrids
made from the poly-(GT) sequence by using sonication of ssDNA with CNT soot,
showed alternating high and low surface profile with an average spacing about 18 nm
[85]. These features, along with observation of the circular dichroism of this material,
led Zheng et al. to propose that poly-(GT) wraps helically about SWCNT with a
proposed pitch of 18 nm spacing [86]. Later measurements of the circular dichroism
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of this material also suggest helical wrapping. However, AFM measurements on
DNA/CNT formed without sonication reveal that adsorbed ssDNA may also forms
a thicker, presumably disordered, layer on SWCNTs that is featureless in AFM
[87, 88, 89].
As mentioned previously, several attempts have been made to disperse SWCNTs
in aqueous solvent using amphiphilic molecules such as surfactants, proteins, or ss-
DNA [90, 91]. In the case of ssDNA, simulations show that the pi-stacking between
the bases and the CNT surface is likely responsible for most of the complex formation
energy. Although the polarization component of the cohesion energy is not negligible
[92]. The formation mechanism of these complexes is not yet completely understood,
but their existence can explain the good solubility of, naturally hydrophobic, CNT
bundles in waterDNA solutions in the course sonication [93].
Figure 2.6: The left image shows DNA wrapped SWCNT viewed along two different
tube axis. The two images in the middle and on the right show certain DNA
sequence recognizing carbon nanotube chirality [94]
Zheng et al. were the first to report that bundled SWCNTs could be effectively
dispersed in water by sonication in the presence of ssDNA [95]. They propose that
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short oligonucleotides with repeated sequences of guanines and thymines (GT)n (n =
10-45), make a nice envelope around a CNT surface with the DNA backbone wrap-
ping round a nanotube with a periodic pitch at an oblique angle of about 45◦ [93]
as shown in fig. 2.3. The DNA bases have been proposed to stack noncovalently
on the surface of the SWCNT through overlapping pi-orbitals.The hydrophobic outer
phosphate groups on the backbone carry negative charge and are exposed to the envi-
ronment. The whole complex becomes water soluble. They also found that wrapping
of CNTs by ssDNA was sequence-dependent. Poly-(A) and poly-(C) sequences have
lower dispersion efficiency than poly-(T) sequence because poly-(A) and poly-(C)
oligomers are known to strongly self-stack in solution and impair the pi-stacking with
CNTs [90, 91].
Gigliotti et al. successfully utilized long genomic single-stranded DNA (>>100
bases) with a completely random sequence of bases to disperse CNTs. These ssDNAs
also formed tight helices around the CNTs with distinct periodic pitches. Although
the helix pitch-to-pitch distances remain relatively constant along the length of a
single CNT, the distances are variable from one DNA/CNT complex to another [96].
In addition, Geckelers group prepared DNA wrapped nanotubes of both MWCNTs
and SWCNTs by a solid-state mechanochemical reaction. The nanotubes were cut
into shorter lengths and were fully covered with DNA, where >90% of the multi-
walled products were 500 nm to 3 µm and 80% of the single-walled products were
250 nm to 1 µm in length, respectively. These products are highly soluble in aqueous
solution with a stability of the suspension of more than 6 months [97].
More recently it has been shown that a sequence-specific motif exists whereby
particular short ssDNA sequences recognize specific chirality SWCNTs, permitting
their separation from a mixture. These recognition sequences, which show high
selectivity towards their respective chirality SWCNT, suggest a highly ordered ss-
DNA secondary-structure. It was proposed that the hybrids are stabilized by base to
SWCNT adsorption as well as by inter-base hydrogen bonding [88]. The evidence for
existence of DNA/CNT recognition sequences suggests a highly specific arrangement
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of ssDNA on the SWCNT surface. DNA β-barrel structures have been proposed as
such an ordered form of ssDNA in which backbone and bases are both arranged
helically on a cylinder [87]. The interior of the structure is hollow and permits the
”insertion” of a SWCNT of a specific diameter. The barrels are generally composed
of two or more strands of ssDNA wrapped helically and stabilized by inter-strand
hydrogen bonding between bases [98]. This conformation allows for all of the DNA
bases to be adsorbed on the SWCNT sidewall as well as for base-to-base hydrogen
bonding for specific sequence and matching barrel symmetry [94].
Figure 2.7: Wrapping of DNA around the SWCNT in a beta barrel configuration [99].
The ssDNA functionalized carbon nanotubes are used in analytical chemistry and
biochemistry: for the creation of nanoscale chemical sensors for various gases and
devices for express recognition of DNA sequences and hybridization. For instance,
the response of DNA/CNT-based odor sensors are specific to the base sequence of
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the ssDNA used. As the number of distinct DNA molecules is extremely large, it
should allow a large family of sensors [100, 101, 102].
Another promising research application in the field of nanotechnology is using
CNTs as gene delivery systems for silencing deleterious genes. Gene therapy is an
important treatment for cancer and other genetic diseases. However, the effects
of gene therapy are limited by the efficiencies of transfection and system delivery.
Macromolecules such as DNA, should not be able to enter through the cell membrane
by themselves, and require carriers to take them inside of cells [91, 93, 103]. Binding
the DNA to the CNTs could protect them from nuclease degradation and, since CNTs
are able to penetrate cells, they could be used as a delivery vehicle[93, 90, 91, 104]. A
study showed that the transfection efficiency of CNTs carrier was 5-10 times higher
than bare DNA; but, much lower than that of liposome [104].
2.4 Photoluminescence of Carbon Nanotubes
The optical properties of CNTs, which allow for a non-destructive characterization of
CNTs containing materials or biological objects, refer specifically to the absorption
in the NIR and visible range, PL, and Raman signals[105].
The emission of photons due to the recombination of an optically excited bound
electron-hole state (exciton) is termed as photoluminescence (PL) [106, 107, 108, 109].
However, these excitons can also decay non radiatively to the ground state. The
exciton lifetime is given by [110]
τ0 =
1
γnonradiative + γradiative
(2.2)
Typical timescales for a non radiative relaxation are in the range of ∼ 40 fs to
100ps and greatly exceed the intrinsic radiative life time of excitons in CNTs which
are about 0.1-10 ns [107, 108].
Individually isolated semiconducting SWCNTs possess non-radiative lifetime in
the upper range 20-100 ps. Thus they can produce measurable PL, whereas the PL
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of large bundles of SWCNTs is very weak because of rapid nonradiative relaxation of
photoexcited charge carriers [108, 111]. Mediated by van der Waals forces, bare CNTs
form bundles in solution, which is detrimental to their bioimaging applications [112].
The use of surfactants to separate the CNTs was shown to substantially increase the
quantum yield of the PL by suppressing non-radiative decay.
The 2D photoluminescence/photoluminescence excitation maps (PL/PLE maps)
are commonly used in optical characterization of SWCNT samples containing multi-
ple chirality species [37, 50, 113, 105]. In such a graph the SWCNT emission intensity
is plotted as a function of the excitation and emission photon wavelengths. PL/PLE
maps give visual correlation between photoexcitation and emission spectra, which
are characteristic for each (n,m) indices [105, 113].
Fig. 2.8 presents a typical PL/PLE map of cobalt-molybdenum catalysis (Co-
MoCAT) SWCNT sample wrapped with DNA and dissolved in D2O. Individually-
dispersed, semi-conducting SWCNTs fluoresce with a high quantum yield. As the
absorption (E22) and emission (E11) peaks strongly depend on the chirality, every
CNT species has a specific combination of E22 and E11 which can easily be used as
a fingerprint.High PL intensities are decoded in red color whereas low intensities are
decoded in blue color [36, 37, 50].
The strongest PL peak at 994 nm seen in Fig. 2.8 corresponds to the excitonic
emission from the lowest subband of (6, 5) SWCNTs. Correspondingly, as a function
of the photoexcitation energy, the intensity of PL at 994 nm reaches a maximum
at an excitation wavelength of about 570 nm, where the excitation is in resonance
with the E22 excitonic subband of the same CNT. The structure of the peaks, both
in PL and PLE, also includes smaller broad features which can be assigned to the
phonon-assisted processes [105].
In this thesis, ssDNA wrapped SWCNTs will be used as a tool to understand the
physics of interaction between nanomaterials and cells. The PL of the DNA/CNT
complex will be used to track their location in the cells and then to correlate their
influence with the structural changes in the cytoplasmic filaments.
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Figure 2.8: PL/PLE map of CoMoCAT ssDNA wrapped SWCNT solution
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Chapter 3
Biomedical Applications of Carbon
Nanotubes
3.1 Uses of Single Walled Carbon Nanotubes in
Nanomedicine
In last decade, CNTs have been intensively researched for in-vitro and in-vivo de-
livery of therapeutics, since cells uptake them without apparent cytotoxic effect to
the cells, when CNTs are properly functionalized [114]. The needle-like CNTs allow
for loading large quantities of materials along the longitude of tubes without affect-
ing their cell penetration capability [115]. With the adequate loading capacity, the
CNTs can carry multifunctional therapeutics, including drugs [15], genes [104] and
targeting molecules [12], into one cell to exert multi-valence functions. Owing to the
high aspect ratio along with the strong mechanical properties and electrically con-
ductive nature, CNTs are excellent material for nanoscaffolds and three dimensional
nanocomposites [116, 117].
In recent year, CNT-based materials have been successfully utilized in tissue engi-
neering and stem cell based therapeutic applications, including myocardial therapy
[118], bone formation [16], and muscle and neuronal regeneration [119, 120, 121].
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Furthermore, owing to the distinct optical properties of CNTs, such as, high absorp-
tion in the near-infrared (NIR) range, photoluminescence, and strong Raman signal
[56, 122], CNTs are excellent agents for biology detection and imaging. Combined
with high aspect ratio of CNTs for attaching molecular recognition molecules, CNT-
based, targeted nanodevices have been developed for selective imaging and sensing
[49, 94, 100, 101, 102].
Figure 3.1: Research based on how CNTs could be used in nanomedicine
CNT Based Delivery System
Many anti-cancer drugs, such as epirubicin, doxorubicin, cisplatin, methotrexate,
quercetin, and paclitaxel, have been conjugated with functionalized CNTs and suc-
cessfully assessed both in vitro and in vivo [123]. The chemotherapy agents can be
bound to a complex formed by CNT and an antibody against antigen overexpressed
on the cancerous cell surface. In this way it is possible to carry the drug mostly at
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the level of the tumor cells. Drugs can be linked with a magnetic CNT complex,
obtained by fixing a layer of magnetite (Fe3O4) nanoparticles on the surface of the
nanotubes. In this case, the system CNT drugs can be guided by an externally placed
magnet to target a desired organ interested by the cancer cell localization sparing
normal counterparts [124].
Surface engineered CNTs based delivery systems have been explored as a new
platform to repair the damaged CNS tissue/cells in the field of neuroscience. The
CNTs have been able to cross the blood brain barrier (BBB) by different target-
ing mechanisms and can be used for targeted drug delivery system [19, 28, 29, 30].
Ren and co-workers developed a dual targeted delivery system based on the oxi-
dized PEGylated MWCNTs modified with Angipep-2 (a targeting ligand of lowden-
sity lipoprotein receptor related-protein (LRP) receptors) loaded with Doxorubicin
(DOX) and systematically evaluated their in vitro and in vivo anti-glioma effect by
C6 cytotoxicity and median survival time of intracranial C6 glioma bearing Balb/c
mice. The combination of O-MWCNTs-PEG with angiopep-2 as targeting ligand was
claimed to play a role of active dual-targeting and combination of O-MWCNTs-PEG
and angiopep-2 constituted an ideal dual-targeting drug delivery to brain glioma [17].
CNT for Stem Cell Therapies
The derivation of neuronal lineages from human embryonic stem cells (hESCs) holds
promise to treat neurological pathologies of the central and peripheral nervous sys-
tem such as Parkinson’s disease, spinal cord injury, multiple sclerosis, and glau-
coma [18, 23, 24, 27]. CNT based substrates have been shown to promote neuronal
differentiation [21, 22, 125]. It has also been proposed that neurons grown on a
CNT meshwork displayed better signal transmission, due to tight contacts between
the CNTs and neural membranes conducible to electrical shortcuts [22]. It was
also demonstrated that the mesenchymal stem cells (MSCs) and the neurosphere of
cortex-derived neural stem cells (NSCs) can grow on the CNT array and both MSCs
and NSCs interacted with the aligned CNTs. The results suggest that CNTs assist
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in the proliferation of MSCs and aid differentiation of cortex-derived NSCs [125].
However, due to the harsh external environment in the host body and lack of
supportive substrates during transplantation, much of the transplanted cells lose its
viability resulting in reduced therapeutic efficacy [126]. Two-dimensional thin film
scaffolds composed of biocompatible poly(acrylic acid) polymer grafted CNTs can se-
lectively differentiate human embryonic stem cells into neuron cells while maintaining
the viability of transplanted cells [125].
CNT for Biomedical Imaging
Photoacoustic imaging is an optical imaging technique that combines high optical
absorption contrast with diffraction-limited resolution of ultrasonic imaging, which
allows deeper tissues to be viewed in living subjects. In photoacoustic imaging,
short pulses of stimulating radiation are absorbed by tissues, resulting a subsequent
thermal expansion and ultrasonic emission that can be detected by highly sensitive
piezoelectric devices. However, many diseases such as cancer do not exhibit a natural
photoacoustic contrast in their early stages [127].
Therefore administering an external photoacoustic contrast agent is necessary.
Owing to the strong light absorption characteristic, the CNTs can be utilized as
photoacoustic contrast agents [128]. De La Zerda et al. first applied SWCNTs for
in-vivo imaging of tumors in mice. In this study, intravenous injection of cyclic RGD
functionalized CNTs to mice bearing tumors showed eight times stronger photoa-
coustic signal in the tumors than mice injected with non-targeted CNTs. This study
suggested that photoacoustic imaging using targeted SWCNTs could contribute to
non-invasive in-vivo cancer imaging [129]. Similarly, Dai et al used the fluorecence
of CNTs to image a mouse cerebral vasculature without craniotomy. Deep infrared
imaging allowed fluorescence imaging to a depth of > 2 mm in mouse brain with
sub-10-µm resolution as shown in fig. 3.2 [111].
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Figure 3.2: Through-scalp and through-skull fluorescence imaging of mouse cerebral
vasculature without craniotomy utilizing the intrinsic photoluminescence of
single-walled carbon nanotubes [111]
Endocytosis
The study of the cellular uptake mechanism of functionalized CNTs has been in-
tensely addressed in the last two decades [130, 131]. The results reported are very
controversial.
The main pathways speculated by scientists for cellular uptakes of tubes are
[132, 133]:
1. phagocytosis,
2. caveolae-mediated endocytosis,
3. clathrin-mediated endocytosis,
4. CNTs piercing into membrane by passive diffusion
Phagocytosis facilitates the uptake of large particles by utilizing cell surface recep-
tors. Receptor mediated endocytosis is a distinct mechanism where internalization
of receptor and its ligand is carried within vesicles [130]. Caveolae are involved in
plasma membrane invaginations of 50 to 80 nm in size including cholesterol. On the
other hand, clathrin-coated pits of 100-200 nm have been shown to be associated
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Figure 3.3: The cellular uptake pathways, subcellular localization and intracellular traf-
ficking of differently functionalized CNTs. (a) Supermolecularly function-
alized CNT via endocytosis, (b) covalently functionalized CNT bound with
drugs via endocytosis, and (c) individual or specifically functionalized CNT
via direct penetration [131, 133, 132]
with the key protein clathrin and other scaffold proteins such as AP-2 and eps15
[134, 135, 136, 137].
Pinocytosis can take place through two different pathways, namely micropinocy-
tosis and macropinocytosis. The former involves the uptake of particles no larger
than 0.1 µm in diameter whereas the latter is carried out with relatively large vesi-
cles (0.25 µm in diameter). Vesicles are the result of cell surface membrane ruffles
folding back on the plasma membrane. Macropinosomes are not coated with clathrin
or caveolin but encircled by actin in its early stages. Macropinocytosis provides
an efficient process for non-selective uptake of nutrients and solute macromolecules
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[138, 139].
Lacerda et al. have demonstrated that the surface modified CNTs enter cells
via an energy-dependent, endosomally mediated cellular internalization approach
and direct cytoplasmic translocation through insertion or passive diffusion in a non-
invasive manner (tiny nanoneedle mechanism) [123, 131, 133, 132].
The functionalized CNTs easily cross the blood brain barriers (BBB) without re-
quiring any external transporter device owing to nanoscale needle-like tubular mor-
phology as the process in fig. 3.3 [123] demonstrate.
Reports have shown that the nanotubes may enter cells rapidly with free traffick-
ing into the cytoplasm in the first hour of internalization [130, 140] . ssDNA-SWCNT
hybrid cellular uptake experiments have shown that tubes tend to accumulate in per-
inuclear endosomes of murine myoblast stem cells, but these hybrids did not enter the
nuclear envelope [141]. Some cells such as the NIH3T3’s can recover from SWCNT
exposure by reducing their intracellular SWCNT concentration through cell division
and active SWCNT expulsion [141]. This penetration of surface engineered CNTs
into phagocytic and non-phagocytic cells is mediated by three alternative pathways
[133]:
1. via membrane wrapping as individual tubes,
2. via direct membrane translocation of individual nanotubes,
3. in bundles within vesicular compartments
The diversity of the proposed mechanisms is potentially due to different surface
modifications, lengths and types of SWCNTs as well as the differences in experi-
mental cell types. The intracellular uptake mechanisms of CNTs are crucial for the
controlled uptake and for understanding how the CNTs influence the cells.
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3.2 Toxicology Reports
The toxicity of CNTs can be influenced by a wide range of factors and character-
istics. Morphology, physical and chemical properties, including size, shape, charge
and/or agglomeration state can be involved in how toxic the tubes are. A well-
coated biopolymer-conjugated SWCNT yields relatively low levels of toxicity. Long
MWCNTs (>10µm in length) have been found to promote carcinogenesis when ad-
ministered through intraperitoneal injection. However, far reduced toxicity is seen
in SWCNTs less than 1µm in length. Metal impurities, which are contained in
non-purified CNT soot, are additional factors that can determine ”CNT” toxicity,
resulting in cell death through various mechanisms including both mitochondrial
destruction and oxidative stress [116, 117].
The toxicity of CNTs on target organs is summarized in fig. 3.4. Respiratory
exposure to CNTs show adverse respiratory effects in experimental animal studies
such as multifocal granulomas, peribronchial inflammation, progressive interstitial
fibrosis, chronic inflammatory responses, collagen deposition, pleural lesions and gene
mutations. Mercer et al. found large differences in the distribution, toxicity and
clearance rates of the CNTs from the lungs, depending on the size of their structures
[142].
Nanodrugs have been observed access the blood stream not only after intravenous
injection but they can cross epithelia of the respiratory tract and pass into the
interstitium and in the vascular system either directly or via lymphatic pathways
also after inhalation. CNTs injected into the blood have also been reported to
induce platelet clotting in the hepatic blood vessels of healthy mice. In addition,
they accelerate the rate of vascular thrombosis in rat carotid artery[117].
Another issue which put CNTs use into question is the biodegradability of the
tubes after their function have been completed. Previous literature suggested non-
biodegradable nature of CNTs and excretion through biliary pathway. However,
few investigations observed that CNTs are degraded in specific environments via
natural, enzymatic catalysis,such as horseradish peroxidase with low concentration
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Figure 3.4: CNTs can be internalized in cells by inhalation, ingestion, or dermal exposure.
Inhaled nanodrugs can pass through epithelia of the respiratory tract into the
interstitium and access the bloodstream directly or via lymphatic pathways.
Successively, the bloodstream transport nanodrugs to the central nervous
system, liver, kidneys, and other organs. Moreover, they can be directly
ingested or alternatively, inhaled CNTs can also arrive in gastrointestinal
tract. Once CNTs are internalized in cells, they can induce organ-specific
toxicity [117]
of H2O2 (approximately 40 mM) at 4
0C over 12 weeks, or in the presence of human
neutrophil enzyme, myeloperoxidase. Most importantly biodegraded nanotubes did
not produce any inflammatory response when aspirated in to the lungs of mice.
Bianco and co-workers investigated the biodegradation of SWCNTs and MWCNTs
under different conditions and concluded that the oxidized MWCNTs were highly
degrading in nature as compared to SWCNTs [143].
A more serious concern is the long-lasting toxicity that new chemical and ma-
terial technologies often presents in ways not detectable by standard toxicity tests.
Although proper modifications and disposal could reduce the toxic nature of CNTs,
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they might still alter the basic behavior of the cells. A recent study showed that
purified and dispersed SWCNTs are not acutely toxic to cells but have an impact
on actin structures with numerous downstream cellular effects. F-actin can organize
into higher-ordered networks and bundles in eukaryotic cells with a host of proteins
to create spatially and temporally unique regions of actin structures. They play vital
roles in cell shape, motility, force generation, division and many other cell functions.
Modulation of the actin cytoskeleton and intracellular force generation within the
cell may alter phenotype and differentiation. Similar in size to F-actin, SWCNTs
have diameters of 1 nm and lengths ranging from 100 nm to a few micrometers. Holt
et al observed that that the cellular actin filaments, which are normally localized to
basal stress fibers, were heterogeneously redistributed to the cellular interior in CNT
treated cells as shown in fig. 3.5 [144, 145].
SWCNTs were also shown to cause significant disruption of the mitotic spindle
at occupationally relevant doses. The increased proliferation that was observed in
carbon nanotube-exposed cells indicates a greater potential to pass the genetic dam-
age to daughter cells. Disruption of the centrosome is common in many solid tumors
including lung cancer. The resulting aneuploidy is an early event in the progression
of many cancers, suggesting that it may play a role in both tumorigenesis and tumor
progression [146, 147, 148].
These results have led us to explore how using a low concentration of CNT solu-
tion, which would be administered for therapeutic purposes with proper non covalent
modification and sterilization method, would signify for a longer time experiment in
stem cells research. The ability of the tubes to penetrate the BBB and CNS mean
that they could influence the neural stem cells. This thesis aims to understand how
this influences normal cell activity and neuronal regeneration.
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Figure 3.5: Reorganization of rhodamine phalloidin-labeled actin inside of SWCNT-
treated cells. (A) Widefield view of the x-y plane of cells. SWCNT-treated
cells show intracellular, perinulear spiky actin projections with little order.
(B) Confocal imaging of isolated cells in the x-z plane with pseudocolor for
rhodamine phalloidin intensity. (C) The localization of actin in cells [144]
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Chapter 4
Neural Differentiation In Vitro
The central nervous system, unlike many other tissues, has a limited capacity for self-
repair in response to injury. While primary neurons are functional, they are difficult
to manipulate and incorporate into existing tissue [149]. Neural stem cells (NSCs),
on the other hand have the ability to differentiate into a variety of neural cells and
integrate into the existing tissue during development and maturation. In the last
few years, increasing knowledge about NSCs has raised hope that stem cell therapy
can be used in the treatment of neurodegenerative diseases such as Parkinson’s or
Alzheimer’s disease [150]. For this to become practical, we need to learn to control
the proliferation of stem cells, as well as the differentiation into different types of
cells. This study aims at using CNTs as an internal perturbation to acquire such
control over stem cells. Tis chapter focuses on the model used for cells.
Stem cells are undifferentiated entities that are able to self-renew and give rise
to at least one, but often many specialized cell types [151]. The self-renewal of a
stem cell is the ability to maintain its own numbers without input from another
cell stage and with no apparent morphological change [152]. The first stem cell in
the developing mammal is a fertilized egg. This cell is characterized as a totipotent
and generates a full functional organism and the placenta. Embryonic stem cells
are called pluripotent, illustrated by their capability to generate every tissue of an
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animal after being grafted into the ovary of a viable female foster animal. The term
multipotent is used to describe the progenitors of different germ layers that have lost
the ability to generate a whole embryo after ovary implantation. Finally, a group of
terms such as bipotent, unipotent, or monopotent is used to describe stem cells with
more restricted potencies [153].
To maintain a stable stem cell population and at the same time produce mature
cells that build up specific tissues, the division of stem cells should be asymmetric,
so that one of the daughter cells differentiates into a mature progeny, while the other
remains a stem cell [154]. There are two basic types of stem cell: adult stem cells,
which are limited in their ability to differentiate, and embryonic stem cells (ESCs),
which are pluripotent. ESCs are not limited to a particular cell fate; rather they
have the capability to differentiate into any cell type [155, 156].
Figure 4.1: Differentiation process of NSCs [156]
NSCs are considered adult stem cells because they are limited in their capability
to differentiate. NSCs are generated throughout an adult’s life via the process of
neurogenesis [153, 156]. NSCs perform vital function in the body specially in central
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nervous system. Studies have shown that their role is primarily during development,
producing the enormous diversity of neurons, astrocytes and oligodendrocytes in
the developing CNS [157, 158]. They also have important role in adult animals, in
learning and hippocampal plasticity, in addition to supplying neurons to the olfactory
bulb [159]. NSCs have been shown to engage in migration and replacement of dying
neurons [160, 161].
Figure 4.2: Oligodendrocytes send projections that wrap around axons in sheathes of
myelin, speeding signal conduction. Microglia are the brains immune cells,
but they also monitor neighboring brain cells for damage and gobble up de-
bris. Astrocytes carry on a host of activities. Their long extensions can
monitor levels of neuronal activity either along axons at synapses and, when
those activities levels are high, signal to local blood vessels to dilate, increas-
ing blood supply to neurons. Astrocytes also produce and secrete substances
that have a major influence on the formation and elimination of synapses
[162].
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4.1 History of Neural Stem Cell Growth in vitro
The realization that the human brain development begins from dividing cells did not
start with the introduction of the term NSC, but at the second half of the 19th century.
Using histological methods, it was observed that dividing cells in the embryonic
human brain are different from the similar cells in other organs. These cells, which
were usually called matrix or germinal, divide close to the ventricular surface (VZ).
Upon neuronal commitment, they stop dividing and migrate to a final position where
they remain for the rest of the individuals life [163, 164, 165, 166]. This concept was
first clearly formulated by Swiss neurologist Wilhelm His (18311904). He made a
simple observation that mitotic figures, cell division in histological preparation, are
localized close to the surface of the human cerebral ventricles but are virtually absent
in the overlying cortex that is forming below the outer boundary between the grey
matter and the cerebrospinal fluid [165]. He concluded that the NSCs produce over
time all classes of neurons, which then migrate from the place of their origin to
increasingly more distant locations. His started the concept that progenitors of the
brain consist of two separate lines that generate neurons and glial cells.
Adult NSCs were first isolated from mouse striatum in the early 1990s. The in
vitro studies of Raff and colleagues demonstrated that a common progenitor existed
for oligodendrocytes and astrocytes [167]. In 1992, Reynolds, Weiss and colleagues
demonstrated that cells could be isolated from the CNS of adult and embryonic mice
and propagated in the presence of epidermal growth factor to give rise to large spheres
of cells that they termed ”neurospheres” [168]. These neurospheres possessed neurons
and glia, but largely consisted of cells expressing the intermediate filament previously
associated with neuroepithelial cells, nestin. They showed that an entire neurosphere
could be generated from a single cell and that this neurosphere could be subsequently
dissociated to produce a new neurosphere that also contained neurons and glia. When
cultured in vitro they are capable of forming multipotent neurospheres, which self-
renew and proliferate into specialized cells. These neurospheres can differentiate
to form the specified neurons, glial cells, and oligodendrocytes [150, 156]. Further
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Figure 4.3: Deep brain stimulation of the anterior thalamus in the mouse with nu-
cleus(blue), neural stem (green), progenitor cells (pink) [166]
studies have shown that cultured neurospheres have been transplanted into the brains
of immunodeficient neonatal mice and have shown engraftment, proliferation, and
neural differentiation [149, 159, 169].
In another, often parallel line of discovery, the potential significance of NSCs in
the adult CNS was established. For a number of years, it was held that there was no
neurogenesis in the adult vertebrate brain. The studies of Nottebohm and colleagues
demonstrated that adult male songbirds had a robust period of neurogenesis during
the spring mating season [170, 171]. As early as 1969, neurogenesis in the adult ro-
dent olfactory bulb was described with confirmation of this work published in 1977
[172]. In 1993 the studies of Luskin [163] and Lois and Alvarez-Buylla [164] clearly
demonstrated that the ongoing proliferation of cells in the adult rodent subventric-
ular zone (SVZ) resulted in new neurons within the olfactory bulb. Although not
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completely proven, current theory holds that within the adult SVZ, a relatively qui-
escent stem cell gives rise to rapidly proliferating progenitors, which then ultimately
give rise to neuronal precursors that migrate into the olfactory bulb to form granule
cells and some periglomerular interneurons. In addition to the olfactory bulb, new
neurons are formed in the adult mammalian hippocampus [166].
The standard method of isolating NSCs in vitro is to dissect out a region of the
brain where dividing cells has been observed, for example, the subventricular zone
(SVZ) or the hippocampus in the adult in the developing brain [155, 173]. Usually,
the tissue is disaggregated and then the dissociated cells are exposed to a high con-
centration of mitogens such as fibroblast growth factor (FGF) or epidermal growth
factor (EGF) in either a defined or supplemented medium on a matrix as a substrate
for binding. These allow the optimal growth of the NSC population, although other
factors synthetized by the cell is also needed [174]. After some proliferation, the
cells are induced to differentiate by withdrawing the mitogens or by exposing the
cells to another factor that induces some of the cells to develop into different lin-
eages [175]. Cellular fates are analyzed by staining with antibodies directed against
antigens specific for astrocytes, oligodendrocytes, and neurons [176].
4.2 Neural Stem Cell Development and Differen-
tiation
NSCs are stimulated to begin differentiation via exogenous cues from the microenvi-
ronment, or stem cell nich [175]. Some neural cells are migrated from the SVZ along
the rostral migratory stream which contains a marrow-like structure with ependymal
cells and astrocytes when stimulated [163, 170]. The ependymal cells and astrocytes
form glial tubes used by migrating neuroblasts [158]. The support for the migrating
cells as well as insulation from electrical and chemical signals released from surround-
ing cells is provided by astrocytes in the tubes [157, 161]. The primary precursors for
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rapid cell amplification are astrocytes. To repair or replace neural cells the neurob-
lasts form tight chains and migrate towards the specified site of cell damage [177].
Neural stem cell proliferation declines as a consequence of aging. Various chemical
approaches have been taken to counteract this age-related decline [178].
In some cases, the fetus-derived stem cells were grafted back to the developing
brain to determine the range of cell types that these cells could differentiate into.
Not only were cells observed to migrate broadly throughout the developing brain and
peripheral nervous system, but also populations containing stem cells derived from
the human fetus could be implanted in the adult rat brain where they differentiated
into neurons and glia [160, 161]. The fate appears to be dictated by the local en-
vironment rather than the intrinsic properties of the cells themselves. Thus, when
grafted to the developing brain, fetus derived stem cells and immortalized progenitor
cells migrate along with the host cells and differentiate into cell types specific for the
target region [158, 179, 180]. An example was in damaged developing brain tissue
where immortalized cells have been shown to migrate to areas of damage, where they
replaced depleted cells [150, 161].
This plasticity is not limited to the developing brain. Stem cells obtained from
the adult hippocampus could be expanded in vitro and implanted back into the
hippocampus, where they generated new neurons and glia, similar to the cells they
generate normally in the adult dentate gyrus [157, 159]. However, these same cells
can generate olfactory bulb neurons when implanted in the rostral migratory stream,
expressing neurotransmitter phenotypes, such as tyrosine hydroxylase, which the cells
do not make in the hippocampus but which are normally generated in the olfactory
bulb [157, 159]. And when implanted into regions that do not normally generate
neurons in the adult (for example, into the intact cerebellum or the striatum), the
stem cells did not make neurons, but they turned into glial cells, which are generated
during injury [159].
In vivo, both chemical and mechanical cues from the cell microenvironment have
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Figure 4.4: The stem cell landscape depicted here illustrates the emerging characteristics
of adult stem cells that include plasticity in cell fate and diversity in origin.
Stem cell (blue) are able to enter diverse tissue compartments via on ramps
and cell types in response to homing signals or growth [181].
been shown to affect differentiation [175]. In recent studies, the impact of the mechan-
ical properties of the extracellular environment and certain chemicals has been shown
to play a large role in determining stem cell fate [182]. For example, in the developing
skeleton, primitive cartilage tissue is usually encapsulated by a rigid perichondrial
membrane. Relaxation of this mechanical constraint by removing the perichondrium
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results in unregulated growth of the remaining tissue [183, 184], likely by allowing
chondroprogenitors cells to continue to grow rather than differentiate into cartilage.
Furthermore, inappropriate development of compressive pressure can lead to ectopic
cartilage formation. In classic tissue explants studies, Glucksmann demonstrated
ectopic cartilage formation in developing bones when bone explants were trapped
between artificial barriers [185]. Similarly, in models of the developing jaw, applied
compression to the mandible joint led to ectopic cartilage formation on the jaw bones
[186, 187] and mechanical compression of the midplatal suture reprogrammed mes-
enchymal stem cell (MSC)-like cells from an osteogenic to a chondrogenic fate [188].
Certain chemical stimuli are also involved in activation and progression of stem
cell differentiation pathways. For example, chemical signals, like growth factors and
cytokines activate specific members of the mitogen-activated protein kinase (MAPK)
signal transduction pathway. Studies have illustrated that this pathway regulates
differentiation of muscle cells, mesenchymal stem cells, and neuronal cells [173, 189].
In vivo, factors such as basic fibroblast growth factor (bFGF) and transforming
growth factor beta (TGF-β) are involved in neuronal differentiation in the neural
tube, leading to development of mature spinal cord [173]. For stem cells of the
central nervous system, ciliary neurotrophic factor (CNTF) is a driver of astrocytic
differentiation, while thyroid III hormone (T3) yields lineage-restricted progenitors
for oligodendrocytes [190].
In vitro studies trying to replicate the controlled cell fate of NSC also uses materi-
als and chemical cues. Stem cells interrogate numerous microenvironmental cues, in-
cluding soluble factors, adhesive contexts, and mechanical signals, in order to mount
physiologically relevant differentiation responses [191, 192] Using knowledge gleaned
from in vivo studies, protocols have been made to optimize the differentiation of
stem cells [189].
Chemical approaches are also powerful tools to manipulate stem cell fate, which
facilitate not only improved generation of desired cell types, but also better under-
standing of the underlying molecular mechanisms. NSCs cultured on glass surfaces
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Figure 4.5: Inherent material properties affects cell fate of stem cells. [193]
modified by different chemical groups, including hydroxyl (-OH), sulfonic (-SO3H),
amino (-NH2), carboxyl (-COOH), mercapto (-SH) and methyl (-CH3) groups, are
shown to commit to phenotypes with extreme sensitivity to surface chemical groups.
The adhering NSCs at the level of single cells exhibited morphological changes in
response to different chemical groups.
NSCs on -SO3H surfaces had the largest contact area and the most flattened
morphology, while those on -CH3 surfaces exhibited the smallest contact area and
the most rounded morphology. The -SO3H surfaces favored NSCs differentiation into
oligodendrocytes, while NSCs in contact with -COOH, -NH2, -SH and -CH3 had the
ability to differentiate into neurons, astrocytes and oligodendrocytes. Compared to -
COOH surfaces, -NH2 seemed to promote neuronal differentiation. These chemically
modified surfaces exhibited regulation of NSCs on adhesion, migration and differen-
tiation potential, providing chemical means for the design of biomaterials to direct
NSCs lineage specification for neural tissue engineering [194].
Pluripotent stem cell (PSC) differentiation is another field where chemical ap-
proaches are especially effective. Pioneering works of ESC differentiation demon-
strated that knowledge gained from in vivo developmental biology provided a basis
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in devising lineage specification strategies [195]. Given their advantages over pro-
tein factors as discussed, small molecules modulating critical developmental signal-
ing pathways have been studied and used to control stem cell differentiation [195].
For example, TGFβ signaling is important for human ESC self-renewal, and meso-
derm/endoderm induction. Inhibition of TGFβ signaling, for example by SB431542
an inhibitor of activin receptor-like kinase favors neural induction of human ESCs
[196]. The pathway inhibitors might function to destabilize self-renewal, to induce
neural lineage and to prevent cells from differentiating into trophectoderm, mesoderm
and endoderm lineages [196].
Much of the work regarding mechanical properties of the extracellular environ-
ment dictating cell fate focuses on substrate elasticity. Many cellular processes,
including cell proliferation, migration, and differentiation are regulated by matrix
elasticity [197, 198, 199]. Previous studies indicate that response to the elasticity of
the extracellular environment is cell-type specific and seems to correlate to the elas-
ticity of the cells native tissue [200, 201]. Increased spreading of fibroblasts occurs
on stiffer surfaces, whereas primary neuronal cells form more neurite branches on
softer substrates [202]. It is believed that cells can sense the stiffness of the matrix
through a feed-back mechanism of the actin-myosin cytoskeleton [200]. Cells are able
to sense extracellular mechanical force in various ways, including stress-sensitive ion
channels, caveolae, integrins, and cadherins [200, 201, 203].
Engler and colleagues demonstrated that plating MSCs on polyacrylamide gels
of varying stiffnesses is sufficient to drive expression of neuronal, skeletal muscle, or
osteogenic markers in the absence of exogenous soluble cues [192]. Cell-generated
tensional forces exist in equilibrium with the underlying substrate (that is, the sub-
stratum develops an equal and opposite counterbalancing force, such that the net
forces sum to zero).
Consequently, it is reasonable to attribute stiffness-dependent changes in stem
cell differentiation to altered intracellular tension. Indeed, addition of blebbistatin to
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block intracellular tension generation in MSCs obliterated stiffness-driven differentia-
tion [192]. Consistent with the hypothesis that cells upregulate intracellular tension
as the matrix stiffens (and provides higher resistance forces), MSCs progressively
assembled actin stress fibers and focal adhesions (tension-dependent structures) in
response to the increasing stiffness of the substrate.
Importantly, these stiffness-mediated cytoskeletal changes are accompanied by
dramatic alterations in cell morphology [192]. While the cell morphology of MSCs
on soft, intermediate, and stiff gels is reminiscent of neurons, myoblasts, and os-
teoblasts, respectively, it is not known whether altered cell spreading is merely a
downstream consequence of differentiation, or rather a primary determinant that
regulates intracellular tension and the mechanical signaling required for specifying
stem cell fate. Nonetheless, the findings of Engler and colleagues are remarkable in
that, unlike other mechanical interventions to date, stiffness appears to have the po-
tential to guide MSCs into multiple fates (rather than the binary switches previously
described)[192].
Moreover, these findings illustrate that shifts in the cell-ECM force balance have
profound effects on stem cell differentiation, and anticipate a major role for dynamic
control of matrix stiffness in controlling tissue development. Indeed, dynamic changes
in the mechanical properties of three-dimensional matrices are emerging as critical
regulators of differentiation [182, 204] and morphogenesis [205]. As such, designing
scaffolds of appropriate matrix stiffness, and understanding how matrix stiffness
couples with other mechanical properties of matrices (e.g., topology features and
structural anisotropy) to control stem cell behavior will be crucial to functional
tissue engineering [206].
4.3 C17.2 Neural Stem Cells
Progenitors removed from the brain do not normally remain in a proliferative or un-
committed state in vitro; after one or two mitoses, they typically cease dividing and
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differentiate. To maintain them in a proliferative, immature, progenitor-like state
requires an intervention [189, 207]. Processes which have successfully circumvented
these limitations have included both genetic and epigenetic means such as immor-
talizing genes into neural progenitors, chronic exposure of progenitors to mitogenic
cytokines, and culture of progenitors on such substrates. These cells, then show a
”stem-like” cell behavior.
After many years of investigation, C17.2 neural stem-like cell line has been shown
to fulfill the functional properties of multipotent NSCs [208]. C17.2 cells were origi-
nally derived from rapidly dividing neuronal progenitor cells in the external granule
layer of the mouse cerebellum. They were immortalized by the retroviral transfec-
tion of the v-myc oncogene and can be cultured to emulate distinct developmental
stages. C17.2 cells respond to specific environmental cues to give rise to terminally
differentiated neurons and glia, thus fulfilling the properties of endogenous neural
progenitors [189, 207].
Fig. 4.6 gives a summary of some of the medical research being done on C17.2
NSCs. Snyder et al. found that C17.2 cells that were transplanted into the adult
mouse neocortex can differentiate into neurons within regions of targeted apoptotic
neuronal degeneration [207]. It has also been reported that grafting these cells to
the nervous system corrects various abnormalities in models of CNS development or
injury [209, 210]. Polyglycolic acid (PGA), a degradable hydrogel, was used as a scaf-
fold in the transplantation of C17.2 into an infarction cavity formed by the ligation of
the carotid artery. These transplanted cells differentiated into neurons and astrocytes
and appeared to form connections with host neurons [208, 211, 212, 213]. Some con-
troversy do exist on this research. Animals showed aberrant axonal sprouting at the
injury site and allodynia- like hypersensitivity of forepaws. Allodynia was observed
after transplantation of C17.2 cells into the injured spinal cord [210, 214, 215].
Data also suggest that intravenously transplanted C17.2 can migrate, prolifer-
ate, and differentiate into neurons and astrocytes in the rat brain with focal is-
chemia and improve functional recovery. One study longitudinally followed C17.2
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Figure 4.6: C17.2 NSCs model [209]
NSC transhemispheric migration towards a stroke lesion in rodent stroke models,
with the migration pattern subsequently confirmed by histology. Such migration
was not observed in non-stroke controls [169, 216]. Furthermore, histology also con-
firmed site-specific differentiation with neuronal-type phenotypes and both neuronal
(NeuN) and glial cell (GFAP) markers were observed [217, 218]. When grafted into
glioma-bearing animals, together with injection of prodrug 5-fluorocytosine, an 80 %
reduction in the resultant tumor mass was observed [219].
Grafts of C17.2 cells, within the dopamine neuron-injured midbrain of adult mice
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that have rescued dopamine neurons in this rodent, for research on Parkinsons disease
[220]. In addition to an apparent neurotrophic rescue of the injured dopaminergic
neurons and their axonal projections, C17.2 cells also gave rise to small numbers of
newly-generated dopamine neurons, and they were also found to migrate to disparate
CNS sites. These cells, therefore, are a relevant modelfot therapeutic treatment of
neurodegenerative diseases [208, 221].
Since NSCs integrate into the implanted tissue and contribute to cerebellum de-
velopment [159, 220], this makes C17.2 cells functional in vivo. Therefore, they are a
relevant cell model for studying neuronal platforms. However, characterization work
of the C17.2 cells in vitro is minimal. Recently, the cells were shown to form synapses
in vitro through the co-localization staining of pre-synaptic and post-synaptic vesi-
cles. This finding is important in the study of NSCs and the development of the
differentiated neuronal cells.
4.4 Differentiation of C17.2
The C17.2 cell line was a generous gift of Dr. Evan Y. Snyder (Harvard Medical
School) [209]. C17.2 NSCs differentiate into neuronal-like cells under defined condi-
tions [222]. One such condition is induced by natural flavonoid, baicalin. Baicalin
promoted the expression of several key neurogenic transcriptional factors enhancing
the activation of Erk1/2.[223].
All-trans retinoic acid (RA) is known to induce differentiation in embryonic stem
cells and in several cell lines. Previous results show that RA seems to promote
astrocyte differentiation rather than neuronal development in C17.2 cells [189].
C17.2 are also prone to differentiate when the nutrients are limited, which oc-
curs unfavorable by fast medium consumption in miniaturized culture environment.
Serum removal media was established to be one such condition. When maintained
in feeding media, C17.2 cells rapidly proliferated and grew to confluence in culture.
Proliferating cells had a polygonal shaped cytoplasm with a large, centrally-located
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nucleus and several short processes that extended in multiple directions [189].
In order to evaluate the consequences of CNT exposure during stages of NSC
development subsequent to cell cycle exit, cells were first grown in their feeding
media, and then transferred to serum-free, media [175].
Immunochemistry analysis revealed that these rapidly dividing NSCs robustly
expressed nestin, a marker for proliferating neural progenitors, but neither the neu-
ronal marker β tubulin III nor the astrocytic marker GFAP. Cells cultured in serum
removal media acquired a neuronal-like morphology, as evidenced by a small round
soma with a centrally-located nucleus and scanty cytoplasm. The cells also had 2
to 3 neurites of varying lengths protruding in opposite directions, creating a bipolar
morphlogy. Cells cultured in these conditions had reduced nestin expression and
increased β tubulin III expression compared to proliferating cells, and were GFAP
negative [176].
Much of the work to control the cell fate of NSCs has been done using external
cues. In this study, I aim to investigate the effect of internal cues, like the introduction
of nanomaterials inside of cells, on NSCs differentiation, including the number of
neurons obtained at the end of differentiation, the shape of the neurons, and the
mode of division (symmetric or asymmetric) [197].
The following chapters investigate how the addition of CNTs affects NSC behav-
ior. Chapter 4 will delve into the methods of using carbon nanotubes. We will discuss
the novel method of purifying the CNTs for use in multi-day experiments, but also
a methodology will be presented for general use of CNTs with biological samples.
Chapter 5 and 6 will explore the differentiation experiment done for 2 separate CNT
samples with DNA and RNA respectively. Finally we will test our hypothesis of
asymmetric division being responsible for the change observed.
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Chapter 5
Methods for Introduction of
ssDNA Wrapped Carbon
Nanotubes to Multi-day
Experiments
A number of studies have been carried out over the past decade which produced con-
flicting results, on how CNTs are affecting cells [17, 116, 117, 143, 142]. These con-
troversial results stem from using different tubes of distinct functionalization under
a variety of experimental conditions and following different protocols. This chapter
aims at developing a methodology of using short CNTs wrapped with biomolecules,
and offers a way to sterilize the CNTs without affecting their structure, and thus
their optical properties and biocompatibility.
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5.1 Using ssDNA Wrapped SWCNT
This section aims at characterizing the CNTs we used. A solution of SWCNTs
wrapped with single-stranded DNA (ssDNA) was prepared from as produced Co-
MoCAT material from Carbon Nanotechnologies Inc. (Houston, TX) and (GT)20
DNA, custom-made by Integrated DNA technologies, Inc. (Coralville, IA). For good
dispersion, DNA: CNT solution are mixed in a 2:1 ratio. For example 1 mg ssDNA
solution is sonicated with 0.5 mg of CNT. Generally, the sonication is performed for
90 minutes at an 8 Watts output power. Following this, the sample should be cen-
trifuged at 16000 g for 90 minutes to precipitate any undispersed CNT. Before the
measurements, the solution of SWCNT wrapped with the ssDNA was centrifuged
using a Microcon spin filter YM100 (Millipore) and re-suspended in deionized wa-
ter with an appropriate concentration to remove the trace of the original buffer.
This procedure is similar to that described in literature [95]. Fig. 5.1 below shows
the optical spectra for absorption and photoluminescence of one such re-suspended
solution.
Figure 5.1: Experimental PL/PLE map of the pure SWCNT solution with circles on the
latter denoting separate chiralities, and absorption spectra of DNA wrapped
SWCNT
The initial solution of 25 µg/ml was then diluted to a less harmful concentration.
The uses of SWCNTs typically involve their dispersion within a cell culture medium,
followed by their subsequent addition to a cell line of interest. However the degree
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of interaction between the SWCNT and the medium in which they are dispersed is
not well characterized. Our study uses well dispersed DNA. ssDNA ionizes in water
solution, thus producing a large linear (negative) charge in ssDNA/CNT complex.
Charged CNTs repel each other, thus preventing the aggregation. Upon removing
the DNA charge, the Coulomb repulsion between the nanotubes cancel, which results
in CNTs, coalesing and eventually crashing out of the solution.
The mechanism for ingestion of the CNT aggregates is very likely to be different to
the individualized SWCNTs [130, 131, 134]. Fig. 5.2 demonstrates the aggregation of
the CNTs in Dulbecco’s Modified Eagle’s Medium (DMEM). Consequently, DMEM
should not be used together with DNA/CNT and needs to be replaced by another
medium. In our case, our dilution of the tubes was performed using a solution of
low potassium Lockes buffer, which was prepared as shown in literature [224]. The
solution was diluted with ddH2O and adjusted to a pH of 7. The mixture was
sterilized by a Puradisc filter with pore size of 0.1 µm. Photoluminescence of the
CNTs in Locke’s buffer are shown in the Fig. 5.2(c) and shows no sign of aggregation.
Figure 5.2: A) CNTs aggregating in DMEM; B) Fluorecent image of CNTs aggregating
in DMEM (large mass of CNTs is seen); C) Fluorescent image of CNTs in
Locke’s buffer (each individual dot corresponds to a diffracted limited image
of CNT)
As prepared, the concentration of re-suspended SWCNTs was at 25 µg/ml of
solution as measured by the absorption optical density [225]. The optimum concen-
tration was determined by incubating the cells with SWCNTs solution for 8 hours
52
and measuring the percentage of survival after a day. We defined the ”Low concen-
tration solution” as the CNTs solution which contains 5ng/ml. We defined our ”High
concentration solution” as being 10x more concentrated. The low concentration was
determined as the point where the photoluminescence of CNTs was still visible under
the microscope. Both low and high concentrations are represented by arrows in the
Table 5.1. The images of the cells after incubation with tubes for 8 hours at both
chosen concentrations which are shown in Fig. 5.4. The low concentration (5 ng/ml)
was much lower than found in a typical treatment in literature, but plausible for use
in biomedical application.
Concentration of DNA/CNT (µg/ml) Cell death %
20 100
15 100
10 95 ± 2
5 85 ± 3
0.5 40 ± 2
0.05 5 ± 2 ←−
0.005 2 ± 1 ←−
Table 5.1: Table was used to determine the optimum concentration of DNA/CNT
5.2 Adding CNT to Cells
The C17.2 cells were grown in cell culture dishes (Corning Inc., Corning NY) in
DMEM high glucose supplemented with 10% Fetal Bovine Serum, 5% Horse Serum,
and 1% L-Glutamine (all from Life Technologies, Gibco, Invitrogen), in a humidified
atmosphere of 5% CO2 in air at 370C. Cells were seeded on glass coverslips at a
density of 10,000 cells per cm2 and allowed to grow to about 80% confluency before
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they were split by using 0.02% trypsin EDTA. All experiments were performed with
cells at passage number 14± 1 days.
The usual amount of DMEM in our dish was 1ml. This solution is replaced by
1ml of Locke’s buffer before addition of SWCNTs solution. The concentration of
CNTs added at the end was 0.005 µg/ml. After a short incubation with SWCNTs
for 8 hours, the cells were washed twice with Locke’s buffer, and regular media was
added to them. The cells were then allowed to grow for a period of 24 days with half
of the media replaced with an equal amount of fresh media, 3 times a week. One
sample of the cells was fixed a day after being incubated with CNTs, and stained
with rhodamine phalloidin. The fluorescence of actin (green) and CNTs (purple), at
the same focus level, have been overlapped and are shown in Fig. 5.3. Images are
then taken at different depths inside to make sure that some CNTs have penetrated
the C17.2 cells. The results confirm the presence of CNTs inside the cells after 24h.
Figure 5.3: Three distinct points along the z-axis of the cell. The letters correspond
to the location on the cell where the image was taken. Green is actin while
purple is CNTs
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Methods
Figure 5.4: Phase Contrast Image of Cells with the 2 Concentration used
We analyze CNT treated sample vs. control which contained both the sample
with ssDNA(no CNTs) and the one with ”no treatment”. As the experiment begins,
all three samples seem to have the same trend. The DNA/CNT trend starts varying
at day 6, and although the cell number still increases, the rate is much slower than
the other two. By day 8, the DNA sample and the ”no treatment” sample are at 100
% confluency.In cell culture, ”confluency” is the term commonly used to refer to the
extent at which the dish is covered by cells. The DNA/CNT keeps increasing until
day 10 but fails to achieve successful completion due to the presence of a biological
contamination, becoming visible at 13 ± 1 day. This experiment was repeated 3
times and resulted in the same outcome. Graph. 5.5 shows the proliferation curve
for the experiment. As observed, there is a cutoff point at around 13 days where the
cells are observed to be contaminated.
The source of the contamination was later discovered to be the SWCNTs. Since
the methods to handle the sterilization of tubes in literature were focused on polymer
functionalized CNTs, and not for biomolecules; such methods would result in dam-
aged or loss of the functionalization of ssDNA, or changes in the structure of CNTs.
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Figure 5.5: Initial Proliferation Curve
Thus, a new process had to be developed. It was found that diluting the SWCNTs
in Penicillin Streptomycin Fungizone (PenStrepF), which is an antibiotic-anmycotic,
available from Life technologies, was an effective technique. 10µl of DNA wrapped
SWCNTs were added to 5ml of Penn Strep and became our main reserve. 10µl of
this stock mixture immersed in 1 ml of Lockes buffer were inoculated with the cells.
This method did not seem to damage the ssDNA wrapping around the tubes, as
verified by the absorption spectra and fluorescence microscopy. This also solved the
problem of contamination in the future experiments performed, as shown in the next
section.
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Results and Discussion
Purification is the initial step and is always desirable before any further usage of
SWCNTs [226, 227]. Bellucci et al. investigated four different sterilization procedures
- treatment in humid heat autoclave, ethylene oxide, irradiation with γ-rays or UV
light and the effect of these procedures on the structural properties and morphological
features of SWCNTS samples by micro-Raman spectroscopy [228]. The best of these
treatments, i.e. the one that least affected the morphology and chemical properties
of CNTs, have been proposed for future use. However, the tubes in my study were
wrapped with ssDNA (GT20) to improve solubility and biocompatibility. A new
sterilization method has been devised to prevent the loss of DNA.
The concentration of tubes in PenStrepF used was 5 ng/ml. This was the low-
est concentration with the highest survival rate, where the tubes could be observed
under the fluorescence microscope. The ”high concentration” was 10x more concen-
trated. The following graphs show the proliferation curve for samples which have
been incubated for 8 hours with Lockes buffer only, DNA/CNT in Lockes buffer and
DNA in Lockes buffer, respectively. As the graph shows, the experiment successfully
completed the 23 days. This was repeated 3 times with success.
Adding PenStrepF to cell cultures is a technique discouraged. Antibiotics-antimycotic
reduces the proliferation of the contamination and these antibiotics center at pre-
venting any of the contaminating microorganisms from growing and do not fix the
problem. However, Kuhlmann et al. showed that a number of morphological and
functional changes can arise from the addition of these agents to cell culture media
[229]. Consequently, these potential interferences with the cells and changes in cell
culture conditions may affect the results of experiments. The lack of standardiza-
tion in cell culture conditions resulting from the use of antibiotics compromises the
comparability of experimental results and could even lead to PenStrepF resistant
microorganisms. For example, penicillin was found to inhibit cell proliferation and
altered protein synthesis [230].
In our experiment, the amount of PenstrepF added to 1ml of Lockes buffer is
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Figure 5.6: Proliferation Curve for Method Designed
5µL, and it was applied for 8 hours only. Since the antibiotics-antimycotic was
removed after 8 hours, it would not conceal any contamination during the following
23 days. The proliferation curve, during the first few days of adding the CNTs with
and without PenStrepF, were also similar. Therefore we concluded that antibiotics-
antimycotics is an acceptable sterilization technique in this experiment.
An intriguing observation was the amount of time before the contamination was
detected. One likely explanation involves the presence of an antimicrobial control
in the experiment which influenced the proliferation of bacteria, until such a control
was reduced by day 15. A literature search suggested that the presence of SWCNTs
affects the proliferation of bacteria.
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In literature, the results from molecular dynamics simulations were used to ex-
plain the higher antimicrobial activity of smaller-diameter nanotubes, such as SWC-
NTs, in comparison to that of larger-diameter nanotubes [231, 232]. The peak of en-
docytosis of SWCNT in this study occurs around 6 hours after incubation [233, 234].
Exocytosis starts happening a few hours after incubation and can last for several
months, although most tubes are exocytose in around a week [233, 234]. Due to
removal of half of the serum every two days, a reduction of SWCNTs should happen.
So, the concentration of SWCNTs left at day 15 might be low enough to allow for
proliferation of bacteria, which would result in an outbreak.
5.3 Conclusion
The addition of PenStrepF to SWCNT before use on biological samples was a novel
method of sterilization which preserved the wrapping around the tubes and prevented
contamination inside the sample. Otherwise, a slow growing infection, which became
apparent after about 2 weeks, was caused by the SWCNT solution, which likely
contained biological contaminants. The addition of PenStrepF did not seem to affect
the proliferation of the C17.2 cells. The image below displays a summary of the
method for introduction of CNTs.
Figure 5.7: Overview of procedure developed in this chapter
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In this study, we postulate that SWCNT caused irrecoverable damage to the bac-
teria by physically changing the outer membrane of the cells, causing the release of
intracellular content. Further studies are necessary to fully understand the reason
behind the delay in bacterial proliferation. However, the antibacterial effect of CNTs
is well supported in the literature. Moreover, our observation of the bacterial infec-
tion closer to the end of the experiment do align with the reasoning that the CNTs
are moderating the growth of the contaminants.
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Chapter 6
ssDNA Wrapped CNT as
Mediators of Neural
Differentiation
Neurodegeneration is the process which happens with the progressive loss of structure
or function of neurons, including death of neurons [235]. Many neurodegenerative
diseases including ALS, Parkinson’s, Alzheimer’s, and Huntington’s occur as a result
of neurodegenerative processes [235]. One possible treatment for these disorders
involves the implantation of neural stem cells to integrate into existing circuitry and
replace damaged cell populations [220, 206]. For these treatments to reach the clinic,
it is crucial to understand the factors affecting neural stem cell differentiation and
to use this knowledge to direct cells into therapeutically useful fates.
Recent studies show that nanosized gold particles (AuNPs) promote the differ-
entiation of human mesenchymal stem cells (hMSCs) into osteoblasts [236]. Gene
profiling revealed an upregulation of Transforming growth factor beta (TGF-β) and
basic fibroblast growth factor (FGF-2) expression that promoted cell proliferation
over osteogenic differentiation in hMSCs [237, 238]. Researchers believe that AuNPs
exerted the effects by interacting with the cell membrane and binding with proteins
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in the cytoplasm, causing mechanical stress on the MSCs to activate p38 mitogen
activated protein kinase pathway (MAPK) signaling pathway, which regulates the ex-
pression of relevant genes to induce osteogenic differentiation and inhibit adipogenic
differentiation. Fig. 6.1 shows the signaling pathway of the interaction [239].
The extracellular signal-regulated kinases/mitogen-activated protein kinases (ERK/MAPK)
pathway is controlled by a signal from a receptor on the surface of the cell to the
DNA in the nucleus of the cell. The signal starts when a molecule binds to the
receptor on the cell surface and produces some change in the cell, such as cell divi-
sion. The pathway includes many proteins, including MAPK, originally called ERK,
which communicate by adding phosphate groups to a neighboring protein, acting as
an ”on” or ”off” switch [239].
This study aims to understand if DNA/CNT would cause a similar shift in neural
stem cell differentiation and act as a mediator for neurons or glial cells. Differentia-
tion of neural stem cells into functional neurons requires various precursor divisions.
A cell begins as a neural stem cell and transitions into a neural progenitor cell. Neu-
ral progenitors can either be basal progenitors or radial glial progenitors, with the
former differentiating into neuron-restricted progenitor cells and the latter becoming
glial-restricted progenitors. Neuron-restricted progenitors, once fully differentiated
and functional, are classified as differentiated post-mitotic neural cells. Internalized
functionalized CNTs could guide neural stem cells to neural fates which would be
beneficial for treatment of neurodegenerative diseases [175, 153]. Ultimately, the re-
sults of this study would help in the control over cell fate and successful integration
into existing cell circuitry via changing the cellular system internally. The cell fate
has been determined through immunostaining [176] of actin [240], nestin, β-tubulin
III [241] and GFAP [242].
The actin cytoskeleton is essential to many important cellular processes, such as
cell division, neuronal polarization, and cell migration [200, 201]. Within the cells,
actin is present in two forms. One is the monomeric, globular molecule called G-actin.
G-actin has the ability to polymerize and create the second form, a double-stranded
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Figure 6.1: ERK/MAPK signaling pathway when AuNP interact with membrane of hM-
SCs [239]
filamentous polymer called F-actin whichbuild up different higher order structures
in cells such as stress fibers [243, 240]. These actin filaments are the ones which are
being stained.
The intermediate filament protein, nestin, is a widely employed marker of NSC’s.
This protein is expressed by many types of cells during development, although its
expression is usually transient and does not persist into adulthood. Such an example
is in nerve cells where they are implicated in the radial growth of the axon. Evidence
from in vitro experiments suggests that nestin plays a role in promoting cell survival
and proliferation [244]. Knockdown of nestin reduced cell growth in cultured neurob-
lastoma and astrocytoma cells. The intermediate filament has also been suggested
to take part in coordinating changes in actively dividing cells, though the biological
significance of these regulations is not clear [244].
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Class III β-tubulin is a microtubule element of the tubulin family found almost
exclusively in neurons. It is widely regarded as a neuronal marker in developmental
neurobiology and stem cell research. β-tubulin III serves a variety of structural
and functional roles, including the formation and maintenance of cell morphology,
mitosis, and cell motility [241].
GFAP is involved in the cytoskeleton structure and provide support to astro-
cytes. GFAP has been used as a marker in determining the stellate morphology of
astrocytes. It is involved in many important CNS processes, including cell commu-
nication and the functioning of the blood brain barrier. GFAP has been shown to
play a role in mitosis by adjusting the filament network present in the cell. During
mitosis, there is an increase in the amount of phosphorylated GFAP [242].
6.1 Adding SWCNT at Different Days during Dif-
ferentiation
Methods
C17.2 neural stem cells were cultured according to accepted protocol. NSCs were
cultured in DMEM high glucose with 10 % Fetal Bovine Serum, 5 % Horse Serum,
and 1 % L-Glutamine. Cells were split at less than 1:10 at least once a week and
kept in a humidified atmosphere of 5 % CO2 in air at 370C. All experiments were
performed with cells at passage number 15 ± 2 days. Cells were fed 3 times per
week by removing half of the old culture media and replacing with an equal amount
of fresh media. For the serum withdrawal procedure, cells were fed with serum-free
culture media, DMEM high glucose with 1 % L-Glutamine. Cells were seeded onto
glass coverslips substrates at a density of 10,000 cells/cm2 and allowed to grow to
about 80 % confluency, at which point the serum withdrawal process began. Cells
were fixed 23 days after the start of serum withdrawal.
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Day Serum %
0 15
1 15
3 7.5
5 3.75
7 1.875
9 0.938
11 0.469
13 0.234
15 0.117
17 0.059
19 0.029
21 0.015
Table 6.1: Serum level at different point during differentiation
At different days during differentiation, a sample group was taken and 3 seper-
ate wells were counted before being treated with DNA/CNT in 1 ml of Locke’s
buffer, (GT)20 ssDNA in 1ml of Locke’s buffer and 1ml of Locke’s buffer respectively.
The concentration of each treatment was adjusted according to the number of cells
present. This treatment was incubated for 8 hours, after which it was washed 2
times with a phosphate buffer. After the treatment, the normal serum removal is
continued.
The ”low concentration” of CNT used was 5 ng/ml for 10 000 cells while the ”high
concentration” used was 10x more. This concentration had to be modified according
to the population of cells at the different days when the CNT solution was added.
(GT)20 DNA, custom-made by Integrated DNA technologies, Inc. (Coralville, IA)
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was diluted in phosphate buffer to a OD(260nm) of 1.0, so as to get a concentration
of 33 µg/mL solution of ssDNA. 16 µl of the dilution and 10 µl of PenStrepF is added
to 1 ml of Locke’s buffer for the DNA treatment. Finally for the last treatment, 10
µl of PenStrepF was added to 1ml of Locke’s buffer. The experimental design is
explained in Fig. 6.2. The sample groups are labeled S1, S2, S3 and S4.
Figure 6.2: Experimental Design
We had 4 different sample groups for days 0, 5, 10 and 15. Before the process of
serum removal is started is labeled as Day 0. The other specific days were selected as
they have been shown to have significant importance by a previous group member,
Colleen Curley [245, 189]. The number of measured divisions has previously showed a
trend peaking at 3.75 % serum, and then dropping off as serum is further withdrawn.
Studies performed on glass substrates has also shown a pattern for frequency of cell
death, peaking at 1.875 % serum, and distinct morphology of neural-like cells which
appear at the same time. It is expected that there would be an increase in cell death
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with reduction of serum as the cells which cannot withstand low serum would die
off. We chose day 10 so that most of these cells would have died off. Finally, on
polyacrylamide gels with collagen, by day 15 of differentiation, more than 70 % of
the cells had turned into neurons.
Results and Discussion
Substrate samples for CNT treatment (the incubation of CNTs at 2 concentrations
at different times during differentiation) and control samples (no treatment and DNA
only) were stained for actin, nuclei, β-tubulin III and GFAP, to assess cell fate. Cells
expressing β-tubulin III were present on all samples, indicating differentiation of the
C17.2 neural stem cells into post-mitotic neurons, as seen in Figure 6.4. The popu-
lation and length of the neurons stained on all three samples seemed very different.
Therefore samples were analyzed for general population and percentages of cell fate
at the end of differentiation. Cultures treated with CNTs resulted in the highest
neuronal population, although the population was affected (decreased) if the tubes
were added at Day 5 of differentiation.
Incubation with carbon nanotubes results in a structured mesh of cell growth
with outstretched and interacting cells. Most of the elongated structures do stain
for β-tubulin III. The different morphology of cells present and the interaction of the
whole meshwork is shown in Fig. 6.3.
GFAP was not found in any images which shows no astrocytes present in culture.
The whole 3.8 cm2 dish was used to analyze the population and the ratio of the
neurons obtained. This ratio was normalized with the population to obtain a more
comparable result. This experiment was repeated three times and the total results
are described below.
On glass substrates, the resulting neural population is usually 3 %. As shown
in Fig. 6.5, this is what is expected without treatment. There is a definite increase
when the cells are treated with CNTs before differentiation. Adding the DNA does
have a small effect when the concentration is high but it is not comparable to the
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Figure 6.3: Phase contrast image of cells incubated with CNTs at day 0 showing the
different morphology of the cells present.
increase seen with CNTs. The population of the treated cells are slightly lower than
the ”regular” one. The ”regular” sample is the one which had no treatment added.
The cell named ”other” are cells that did not stain for the dyes mentioned above.
These cells still need to be characterized.
Treating cells with CNTs at day 5 decreases the population drastically at the end
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Figure 6.4: Images were taken at different position on petridish which results in the
varying cell densities. These images were randomly taken on plate to show
cells under different treatment at Day 0, fixed after differentiation. Red is
actin stress fibers, green is nestin filament, blue is the nucleus, and grey is
β-tubulin III filaments. No GFAP was observed.
of the differentiation period. All 3 experiments showed a considerable difference be-
tween the population of cells that had been incubated with CNTs and the cells which
had not. Treatment at day 5 is also the only day where increasing the concentration
of CNTs decreases the resulting neurons but increase the number of uncharacterized
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Figure 6.5: Population analysis for treatment done at Day 0. The histogram shows the
population for each treatment administered at day 0 with their respective
concentrations. Pie charts analyze what each of the population consist of in
terms of differentiated cells.
cells.
Incubation of cells with CNTs at day 10 seems to show an increase in the final
population. The presence of the uncharacterized cells is significant to the neural pop-
ulation. However, increasing the concentration of tubes seems to have the opposite
effect than on the previous figure. The neural population seems to remain constant
but there is an increase in undifferentiated cells. The other controls seem to show
regular behavior expected on glass.
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Figure 6.6: Population analysis for treatment done at Day 5. The histogram shows the
population for each treatment administered at day 5 with their respective
concentrations. Pie charts analyze what each of the population consist of in
terms of differentiated cells.
For the final figure, day 15 a similar effect is observed. Increasing the concen-
tration of CNTs shows a more pronounced increase in cells expressing the neuronal
marker in this case but a decrease in the cells which are not expressing the typical
markers. The population is still slightly elevated for cells which have been incubated
with a higher concentration of CNTs at day 15.
It is our hypothesis that these uncharacterized cells would be either an unreactive
glial cell, a supporting cell such as a fibrolast or cancer cells. Further studies need
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Figure 6.7: Population analysis for treatment done at Day 10. The histogram shows the
population for each treatment administered at day 10 with their respective
concentrations. Pie charts analyze what each of the population consist of in
terms of differentiated cells.
to be done to figure out the cell type.
Although there is a definite increase in the number of cells expressing neural
marker β-tubulin III, the cells themselves are a little peculiar. The protein is being
expressed inside of the nucleus in some of these cells.
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Figure 6.8: Population analysis for treatment done at Day 15. The histogram shows the
population for each treatment administered at day 15 with their respective
concentrations. Pie charts analyze what each of the population consist of in
terms of differentiated cells.
6.2 Symmetric Division versus Asymmetric Divi-
sion
For normal development, there must be a proper balance of symmetric and asym-
metric division events [246]. Symmetric cell division results in two daughter cells
with the same developmental fate, and serves primarily to expand the pool of pro-
genitor cells [247]. Asymmetric division events, however, result in two daughter cells
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with different developmental fates, and therefore give rise to the cellular diversity in
multicellular organisms [246, 248]. During differentiation of neural stem cells, the
balance of these processes affects the composition of the cell population [249]. It
has been shown that both mechanical and chemical cues contribute to produce the
final fate of a cell [175, 182, 195, 245]. In this section, an assessment is made on the
rate of symmetric and asymmetric divisions occurring when cells are treated with
CNTs before differentiation, starts and 5 days after differentiation is underway, to
investigate if the difference in cell division might explain the change in population
composition observed.
Figure 6.9: Fraction of asymmetric division events throughout serum withdrawal [245]
A previous group member studied the rate of asymmetric division through a time-
lapse image captured at various serum concentrations throughout differentiation of
C17.2 cells on glass and other substrates [245]. Data showed lower frequencies of
asymmetric divisions earlier in serum withdrawal. This may indicate a delayed start
of differentiation. The data indicated that by the final observed point of serum
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withdrawal, there are a higher number of asymmetric division on the glass than on the
gel, most probably due to the significant amount of cells that have not differentiated.
The data obtained previously by Colleen Curley compared the division on different
substrates and is shown in fig. 6.9 [245]. The asymmetric events here are described
as the divisions in which the area ratio of the smaller daughter to the larger daughter
is less than 0.7. This study is expanded in the following section to be compared with
cells treated with CNTs [245].
Methods
Time-lapse imaging was performed with the Nikon Biostation IM over extended
periods of time, with pictures of differentiating cells captured every 15 minutes for
10 days for each treatment. The treatment involved incubation with DNA/CNT at
day 0 and day 5 and incubation with DNA at day 5. All treatment incubation time
was 8 hours, and then washing twice with a phosphate buffer. Every two days, half
of the media was replaced with serum free media, to force the differentiation of the
cells. Fluorodishes of 35 mm were used for cell observation on the biostation, with
cells seeded at a density of 10 000 cells/cm2, similar to previous section.
Daughter cell size quantification was performed using ImageJ software. The size
of each daughter cell was measured after each captured division. The ratio of the
area of the smaller to the larger daughter was calculated, and asymmetric divisions
were defined as those in which this ratio was less than 0.7 or which divided into more
than two daughter cells [245].
Results and Discussion
For each data point presented, images were captured at 25 different areas in a single
dish. Fig. 6.10 shows data from a 48 hour biostation run for the treatments men-
tioned above, with images captured at 20x magnification every 15 minutes. There
were up to 20 divisions counted. The large error is associated with a difficulty in
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counting the divisions due to a high density in the population during the first 10
days. Moreover, an interruption occured in the biostation during the experiment at
day 7 for the DNA/CNT added at day 0 and instead of 48 hours, only 32 hours could
be taken into consideration.
Figure 6.10: Fraction of asymmetric division events throughout serum withdrawal for
various treatment
The number of divisions were observed to peak at different times for the 3 treat-
ments. When CNTs were added at day 0 (15 % serum), the highest number of
divisions occurred at day 3 of differentiation, while when tubes were added at the
later time, the peak was detected 2 days after the treatment at day 7 (1.875 %
serum). The DNA seemed to be in congruence with the no treatment where the
number of measured divisions were highest at 3.75 % serum (day 5).
The asymmetric division on glass still seemed to show the highest increase at
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serum 0.94 % (day 9). However, the rate was much less when adding carbon nan-
otubes before differentiation. Asymmetric division drops at 3.75 % (day 5) serum,
and then increases with the progression of serum withdrawal, and the presumed
differentiation of the cells into their final, postmitotic state. Previously, on differ-
ent stiffness of substrate, less prominent asymmetric division was observed when
the serum removal is at 1.875% (day 7). Lower frequency of death at day 5 (3.75
% serum), observed earlier in samples not treated with CNTs, could indicate the
reason for the population difference between the treatment of DNA/CNT and the
controls. For the dish treated with CNTs before differentiation (day 0 and 15 %
serum), the data might be indicating more cells being specialized into their final cell
fate by the final observed point of serum withdrawal which is why we have a lower
rate of asymmetric division at day 9 (0.938 % serum)
On the other hand, we observe a very high rate of asymmetric division for the
cells that had been incubated with CNTs at day 5 when the serum level drops to
below 1 % (after day 9). Almost half of the divisions occurring are not symmetric.
6.3 Conclusion
In this study it has been shown that adding CNTs during the process of differentiation
is favorable for neural stem cell specializing into neurons. There is further control of
the cell fate depending on when during differentiation the CNTs are added. C17.2
neural stem cell also mature into another cell types which do not react to the general
stains used for this cell line.
This diversity in population leads us to probe asymmetric division events since
this type of division results in different developmental fate. An increase in asymmet-
ric division could be observed for cells which had been incubated with CNTs.Asymmetric
division rate was measured vs. time and showed maximum at a certain day. This
peak was different according to the day at which the treatment was given. Also,
the division events were different for the treatment of CNTs which would lead to a
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difference in population by the end of the differentiation period.
These results add further information to build in the future model on the role
of CNTs in stem cell differentiation, where the internal cue is used to influence the
neural stem cell differentiation instead of the external environment.
Future work will more closely examine the asymmetric division throughout the
whole differentiation period for different incubation days of the CNTs. Also, the
pathway to differentiating these cells and the effect that CNTs have on it will be
investigated.
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Chapter 7
Transfer RNA Wrapped CNT as
Mediators of Neural
Differentiation
Studies with AuNP suggested that various functional groups such as amino, carboxyl
and hydroxyl groups could promote or inhibit stem cell differentiation [238]. The
different surface functionalized AuNPs did not show acute toxicity on the hMSCs.
However, positively charged AuNPs showed higher cellular uptake and did not inhibit
osteogenesis but certain metabolistic activities were reduced in AuNP treated with
COOH [238]. Since functionalization with different functional group seemed to give
distinct results, in this chapter, the focus was investigating if changing the wrapping
of the SWCNTs would affect the results obtained from the previous chapter. Transfer
ribonucleic acid (t RNA) was used as a comparison for the results obtained with
ssDNA wrapping.
t RNA is a necessary component of protein translation as it is directly involved
in protein synthesis. The process by which messenger RNA (m RNA) directs protein
synthesis with the assistance of t RNA is called translation [250].The ribosome is a
very large complex of RNA and protein molecules. Each three-base stretch of mRNA
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(triplet) is known as a codon, and one codon contains the information for a specific
amino acid. As the m RNA passes through the ribosome, each codon,the triplet of 3
bases in m RNA, interacts with the anticodon,the corresponding 3 bases in t RNA.
Many maternally inherited and incurable neuromyopathies are caused by mutations
in mitochondrial (mt) t RNA genes. Import of an endogenous cytosolic tRNAs
restored mitochondrial function and could be used in the future for the management
of such genetic disorders [251].
So the following chapter will discuss how CNTs wrapped with t RNA affects the
differentiation of C17.2 stem cells. We will also discuss the changes which wrapping
with another biomolecule brings to the cell fate of the stem cells. The results obtained
might offer an insight into the cause of these observed changes in the previous chapter,
and might further help in gaining control on differentiation of neural stem cells.
7.1 Adding SWCNT at Different Days During Dif-
ferentiation
Methods
The low concentration of CNT used was 5 ng/ml for 10 000 cells while the high
concentration used was 10 times higher. This concentration had to be modified
according to the population of cells at the different days when the CNT solution
was added as described in the method with DNA/CNT in the previous chapter. So
the cells were counted before the treatment. Sigma t RNA from baker’s yeast was
diluted in phosphate buffer to a OD(260nm) of 1.0 so as to get a concentration of
40 µg/mL solution of RNA. The concentration of RNA used was the one specified
by the as produced production of the wrapped CNT. 15 µl of the dilution and 10
µl of PenStrepF is added to 1 ml of Locke’s buffer for the RNA treatment. Finally
for the last treatment 10 µl of PenStrepF was added to 1ml of Locke’s buffer. We
had 4 different sample groups for days 0, 5, 10 and 15. Before the process of serum
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removal is started is labeled as Day 0.
Results and Discussion
Figure 7.1: Population analysis for treatment done at Day 0. The histogram shows the
population for each treatment administered at day 0 with their respective
concentrations. Pie charts analyze what each of the population consist of in
terms of differentiated cells.∗ = p < 0.1,∗∗ = p < 0.05, ∗ ∗ ∗ = p < 0.01
Immunochemistry analysis were then performed on the fixed cells for the nucleus,
actin, β-tubulin III, nestin and GFAP. The population of the cells were counted using
the nucleus and we were also interested in collecting a ratio of β-tubulin III to nestin
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to GFAP, which would give us a comparison to the DNA/CNT treatment. β-tubulin
III appeared on all plates while GFAP did not stain any of our cells.
The experiment was repeated 3 times and analysis was done on the results. The
results of DNA/CNT are included in the figures for cell population for comparison
purposes. Similar trends are seen on all the graphs and adding CNTs increases the
neural outcome together with an uncharacterized cell percentage. Different concen-
tration and days when the treatment was added during differentiation can influence
cell fate. All three types of cells are present in the population when CNT is added;
however the percentages vary.
Statistical significance between the population of DNA/CNT and RNA/CNT
was evaluated with a paired Student’s t-test for comparison on dependence of the
mediating factor on the CNT. This comparison would help us understand if it is
indeed the CNTs which are responsible for the favorable neuronal differentiation and
the presence of the uncharacterized cells inside our differentiated culture. This is
shown for each of the graphs by the p value. A high p value indicates that the
results were inconclusive and that the null hypothesis cannot be rejected. The null
hypothesis is typically the accepted status quo. The alternative hypothesis is usually
the one we are more interested in. When dealing with p-values alone, the alternative
hypothesis needs to be the only possible alternative. That way, if we reject the null
hypothesis, we can safely accept the alternative hypothesis, and state a conclusive
result. The p value is obtained from the t- test following the equation written below.
t =
x¯1 + x¯2√
S21
n1
+
S22
n2
(7.1)
where, x¯1 = Mean of first set of values; x¯2= Mean of second set of values; S1 =
Standard deviation of first set of values; S2= Standard deviation of second set of
values; n1= Total number of values in first set; n2= Total number of values in second
set.
The same sudden decrease in population is observed when the cells are incubated
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Figure 7.2: Population analysis for treatment done at Day 5. The histogram shows the
population for each treatment administered at day 0 with their respective
concentrations. Pie charts analyze what each of the population consist of in
terms of differentiated cells.∗ = p < 0.1,∗∗ = p < 0.05, ∗ ∗ ∗ = p < 0.01
with tubes at day 5. The RNA does not seem to be changing the population much.
There might even be a slight increase observed.
The results seem to suggest that the differences in the population and outcome
in diversity of cell fate does not change when the material being wrapped around the
tubes is still a biomolecule.
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Figure 7.3: Population analysis for treatment done at Day 10. The histogram shows the
population for each treatment administered at day 0 with their respective
concentrations. Pie charts analyze what each of the population consist of in
terms of differentiated cells.∗ = p < 0.1,∗∗ = p < 0.05, ∗ ∗ ∗ = p < 0.01
7.2 Adding SWCNT at Day 0 of Differentiatiation
and Stopping at Different Days
If the wrapping did not change the outcome of the experiment, the cell fate de-
cision to become neurons might be triggered by the CNTs. Through observation,
morphological neural-like cells appeared by day 7. So, we added the CNTs before
differentiation started and fixed after a few days during the process. The neural
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Figure 7.4: Population analysis for treatment done at Day 15. The histogram shows the
population for each treatment administered at day 0 with their respective
concentrations. Pie charts analyze what each of the population consist of in
terms of differentiated cells.∗ = p < 0.1,∗∗ = p < 0.05, ∗ ∗ ∗ = p < 0.01
population was investigated.
Methods
C17.2 were seeded onto glass coverslips substrates at a density of 10,000 cells/cm2.
At this point, 5 ng/ml of RNA/CNT/PenStrepF was added to a 1ml solution of
Locke’s buffer. This solution was incubated for 8 hours, after which it was washed
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2 times with a phosphate buffer. This was day 0 of the serum removal procedure.
Similar procedure were performed for the controls, RNA/PenStrepF and PenStrepF.
Cells for each treatment were fixed at day 7, 14, 21.
Figure 7.5: Experimental Design
Results and Discussion
Immunochemistry analysis were then performed on the fixed cells for the nucleus,
actin, β-tubulin III, nestin and glial fibrillary acidic protein. The population of the
cells were counted using the nucleus and we were also interested in collecting a ratio
of β-tubulin III to nestin.
The results from the pie charts show that β-tubulin III expressing cells start
appearing by day 7 in cells incubated with CNTs. By day 10, a significant portion
of the cells have started becoming neurons.
7.3 Conclusion
Changing the biomolecule used to wrap the CNTs still promoted neural cell fate.
The results obtained in the previous 2 chapters highly suggest that the addition of
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Figure 7.6: Population analysis for different treatment during differentiation. Cells were
fixed at day 7,14 and 21 days. Immunostaining was performed to determine
cell fate of cell.
CNTs during differentiation provides a neural mediator to the stem cells. The trends
of incubating with RNA/CNT were very similar to the DNA/CNT ones.
The cell fate decision to become neurons during differentiation changed in the
presence of CNTs . Differentiation happened earlier compared to in the absence of
the nanomaterial.
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Chapter 8
Conclusion and Future Work
8.1 Conclusion
With growing interest in the application of CNTs in biomedical and clinical research,
possible toxicity of CNTs is becoming an increasingly important issue. A number
of studies have been carried out over the past decade which produced conflicting
results, leading to divergent views about the actual safety of CNTs in health related
applications. These controversial results stem from using tubes of distinct function-
alization under a variety of experimental conditions and following different protocols.
In this study, we developed a simple novel method of introducing ssDNA wrapped
CNTs to cell cultures without contamination by using PenStrepF.
This method was used to apply DNA and RNA wrapped CNTs to NSCs. Both
complexes have been shown to guide stem cell differentiation into neurons. Adding
CNTs during the process of differentiation is conducive to neural fate. Further control
can be achieved by changing the days during differentiation at which the CNTs are
added. An increase in asymmetric division could be observed for cells which had
been incubated with CNTs. Depending on when CNT treatment was performed
during differentiation caused asymmetric division to increase at different days. C17.2
neural stem cell under CNT treatment also mature into another cell type which do
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not stain for the general dyes used in the lab. The neurons which were formed had
some irregularities to them in that they expressed β-tubulin III in the nucleus.
Changing the biomolecule used to wrap the CNTs did not deter the mediator
aspect of the cells to promote neural cell fate. The trends of incubating the cells
with RNA/CNT were very similar to the DNA/CNT ones. Further probing of the
cell fate with RNA/CNT showed that the presence of neurons were observed earlier
compared to the samples with no treatment.
Further experiments need to be performed to uncover the mechanism causing the
changes observed and to optimize the capability of the CNTs to be a mediator for
neuronal differentiation. The next few sections discuss the premises for these future
experiments and the reason why they would be a viable next step in understanding
the use and limitations of CNTs.
89
8.2 Future Work
8.2.1 Correlation of Cytoskeletal Filaments with ssDNA Wrapped
SWCNTs
The cytoskeleton plays a large role in the guidance of the axonal growth cone and
formation of synapses. It also is largely involved in spindle orientation during cell
division. Migration, differentiation, apoptosis and proliferation have been affected by
actin stress fiber alignment and cell body alignment. The cytoskeleton of the cell is
comprised of dynamic polymer fibers (microtubules, actin filaments and intermediate
filaments), which is the main mechanical aid in the interaction with the external
environment and the neighboring cells [200, 201].
Actin fibers, concentrated at the membrane and the bottom of the cell, help with
mobility and cell-to-cell and cell-to-substrate connections via integrins [243, 240].
Approximately 10 nm in diameter, integrin receptors are able to transmit surface
cues into signals for various cellular processes [203]. The clustering of integrins
and the formation of focal adhesions are both necessary processes in the signaling
cascade. These clusters and focal adhesions are on the order of nanometers in size.
Additional cellular proteins contained in focal adhesion complexes are α-actinin,
cinculin, paxillin, tallin and vinculin [252]. In particular, the protein paxillin interacts
with both the integrin and the actin cytoskeleton [252]. The proteins in the focal
adhesion complex and the corresponding intracellular actin sense signals from the
surrounding environment. Chemical or mechanical changes on the cell surface will
influence the integrin-focal adhesion signaling cascade [201].
These changes result in variances in cellular processes such as differentiation,
proliferation and migration [201, 203, 252]. We propose to quantitatively describe
the disruption and changes in the cytoskeletal filaments and correlate the position of
the fibers to the CNTs positions to explain the results obtained in the two previous
chapter. Furthermore, an investigation of changes in integrin-focal adhesion is pro-
posed. If cytoskeletal filaments are changed, an assumption can be made that this
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will disrupt the integrin-focal adhesion signaling cascade, which will in turn affect
the adherence of the cell. This would potentially lead to similar effects as a change
in external mechanical cues would achieve.
Preliminary Results
Figure 8.1: Actin stress fibers in a cell with no treatment.
The actin stress fiber diameter does not seem to change substantially with CNT
treatment. However the number of actin fibers inside the cell is increased after being
treated with DNA/CNT. We would also like to quantify how this changes the shape
of the cell.
91
Figure 8.2: Actin stress fibers in a cell treated with DNA/CNT. Cell fixed 24 hours after
the incubation period.
Using Manders correlation function for the entire cell, we find that 80 ± 10 %
of the CNTs image colocalizes with the actin image at the same point in the cell
while only 33 % of the actin pattern overlaps with the CNT image. This corresponds
to the qualitative observation that the actin photoluminescence covers a larger area
compared to the SWCNT fluorescence signal. Since only 5 cells have been analyzed
so far, this produces large errors. We would like to increase our statistical relevance
in the future, and do the same experiment for nestin fibers.
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Figure 8.3: Distinct points along the z-axis of the cell with CNTs in focus. Green is
actin while purple is CNTs
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8.2.2 Optimizing Differentiation Through External and In-
ternal Cues
Figure 8.4: Neuron images on surfaces with different Young’s modulus(a.)140 Pa,
(b.)1050 Pa, (c.) 60000 Pa. β- tubulin III (green), actin (red), nuclei (blue)
; Graph of Substrate Stiffness vs. Neurite Length [245]
Previous research by Colleen Curley demonstrated that neurite length decreases
with increasing substrate stiffness, shown in Figure. 8.4. The softest substrates
(140 Pa) facilitated formation of the longest neurite extensions and synapses, pos-
sibly indicating that soft substrates with mechanical properties similar to the brain
support neuronal differentiation, and promote neurite growth.Synapses consist of
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pre-synaptic specializations on the cell that is sending the signal, a synaptic cleft
between the two neurons, and a post-synaptic specialization on the cell that receives
the signal [245].
These studies have shown a differentiation result of 3% neurons at the end of the
23 days on glass. In this thesis it has been shown that depending on the concentration
and the day at which CNTs are added during differentiation, more than 3% neurons
can be obtained on glass substrate. In fact at day 5, at high concentration, about
45% of the cells were stained with β-tubulin III.
Therefore, the conditions to guide the neural stem cells to neural fates which
would be beneficial for treatment of neurodegenerative diseases, could still be opti-
mized. Ongoing studies is being done by adding carbon nanotubes to neural stem
cells being differentiated on the polyacrylamide gel substrates treated with collagen.
Initial results performed by another member of the group are shown below.
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Preliminary Results
Figure 8.5: A) Image shows neural like morphology for cells differentiated on a 140 Pa
gel B) Image shows neural like morphology for cells differentiated in presence
of CNTs
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8.2.3 Tracking of SWCNTs During Differentiation
Although several possible mechanisms have been proposed for cell internalization of
CNTs, the exact mechanism of cellular binding and the dynamic fate of the inter-
nalized CNTs continue to raise significant debate. The method of introduction of
CNTs might affect the functionalization of the tubes. If endocytosized, the intrav-
esicular pH drops along the endocytic pathway, from pH ∼ 6 in early endosomes to
pH ∼ 4.5 in late endosomes and lysosomes [253, 254]. At low pH, the wrapping of
the ssDNA might be affected after endocytosis. Membrane transport through endo-
somal compartments can also be perturbed by agents that interfere with endosome
acidification, such as membrane-permeant weak bases, like chloroquine.
Kelley and coworkers reported that the PL of double stranded DNA-wrapped
semiconducting nanotubes is dependent on pH [255]. Variations in pH have also been
used to control the aggregation of DNA/CNTs [256]. Although ssDNA is able to dis-
perse SWCNTs in water at pH 7 through non-covalent wrapping on the nanotube
surface, at lower pH, an alteration of the DNA secondary structure leads to precip-
itation of the SWCNTs from the dispersion. However, this seems to be reversible
on restoring the pH to 7, where the DNA again relaxes in the single-stranded form
[257]. This implies that the wrapping of the tubes might be lost inside the endosome,
which are slightly acidic. However, These experiments were done in the presence of
excess DNA solution. Here, we propose a study of conjugate migration, where the
SWCNTs are wrapped with DNA which has been tagged with a fluorescent molecule.
A map of where the SWCNTs and tagged DNA are migrating inside the cell would
allow us to determine the cellular binding and the dynamic fate of the internalized
CNTs as compared to the DNA.
At different days of differentiation, the DNA and CNTs could be interacting with
different parts of the cells changing the outcome of the cell fate. Therefore, I propose
that the method described above is used to track the CNT and DNA and measure
their interaction with different organelles. At full serum, the carbon nanotubes were
tracked for a few days and appeared to remain in the perinuclear region. One of the
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hypothesis behind the difference in cell fate is that the CNTs are interacting with
the nucleus changing the genetic coding of the cell, thus controlling the cell fate.
Preliminary Results
Figure 8.6: At full serum, the CNTs seem to stay in the perinuclear region
Figure 8.7: CNTs were tracked inside cells which were at full serum after incubation for
8h
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Appendix-Calculating
Concentration of DNA needed for
Low Concentration
8.3 Appendix
Calculating the number of CNTs inside solution
Number of hexagons per unit cell,
N =
2(n2 + nm+m2)
dt
(8.1)
where dt=gcd(2n + m, 2m + n)
Unit cell of (6,5) CNTs contains 364 carbon atoms. For a 500nm long CNTs which has
123 unit cells contains a total of 44772 carbon atoms. The translational periodicity
of the unit cell is 4nm long.
Total mass of SWCNT = 537264 Da ∼ 8.92 x 10−19g = 1 CNT. The conversion
factor was 1.661 x 10−24g per Dalton.
We could then calculate the number of CNTs in the 1ml solution for low concentration
solution which was 0.05 µg/ml. This gave us 5.6 x 1010 CNTs, with an average
distance between CNTs in solution of approximately 2.61 µm.
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Corresponding number of free DNA inside solution,
if completely unwrapped from nanotube
The reference [258] provides charge of the DNA/CNT complex to be 6.0 ± 1 e−/nm
for (6,5) CNT. This corresponds to 6 ionized phosphate group and sequently 6 nuclear
basis per nanometer of nanotube length. For a 500 nm long tube, it gives 75 GT20
oligomers.
For all the CNTs in 1ml of solution, the total number of DNA strand present in the
solution is approximately 4.2 x 1012 oligomers.
Calculating the weight of DNA needed for Low
Concentration
We started by converting the number of DNA molecules present to a molar con-
centration and obtained 6.98 nMolar. IDT DNA gave the relationship as 8 nM is
contained in 100.3 µg of solution. We would like 89 ng/ml.
The stock solution of GT20 DNA according to the OD is 33µg/ml. 3.7 µl of the stock
solution dissolved in 1 ml of Locke’s buffer gives the required concentration.
In the control experiment, the DNA solution was 41.4nM, which is 6 times more
than the maximum concentration of free DNA if it would completely unwrap from
the CNT.
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”I may not have gone where I intended to go, but I think I have ended up where I
needed to be.” -Douglas Adams
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